Molecular functions of endogenous and heterologous genetic RNA elements in the tick-borne encephalitis virus genome by Rouha, Harald
  
 
 
 
 
DISSERTATION 
 
Molecular functions of endogenous and heterologous genetic 
RNA elements in the tick-borne encephalitis virus genome 
 
 
 
angestrebter akademischer Grad 
Doktor der Naturwissenschaften (Dr. rer. nat.) 
 
 
 
 
 
 
 
 
Verfasser: Harald Rouha 
Dissertationsgebiet Genetik und Mikrobiologie 
Betreuer: Univ.-Prof. Dr. Timothy Skern 
Univ.-Prof. DDr. Christian Mandl 
 
 
 
Wien, im Juni 2010 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Danksagung 
 
 
 
 
  
Die vorliegende Arbeit entstand zwischen März 2007 und Mai 2010 am Department für Virologie der 
Medizinischen Universität Wien.  
 
Mein Dank gilt vor allem Prof. Christian Mandl für die exzellente wissenschaftliche Betreuung dieser 
Dissertation, für seinen ansteckenden Optimismus und für all die wertvollen Diskussionen und 
Gespräche, auf die ich auch nach seinem Weggang vom Institut nicht verzichten musste. Ohne seinen 
transatlantischen Input wäre der Abschluss dieser Arbeit wohl kaum möglich gewesen. Weiters 
möchte ich mich bei Herrn Prof. Franz Heinz bedanken, der es mir ermöglicht hat, diese Dissertation 
am Department für Virologie durchzuführen und den ich stets und in allen Belangen um Rat fragen 
konnte. Herrn Prof. Tim Skern danke ich herzlich für die Übernahme der Betreuung nach dem 
Weggang von Herrn Prof. Mandl und Caroline Thurner für die interessante Zusammenarbeit mit der 
„Theoretischen Chemie“ und für die Möglichkeit in einem ihrer Projekte gestaltend mitzuwirken. Ein 
großes Dankeschön möchte ich auch allen momentanen und ehemaligen Mitarbeitern des 
Departments/Instituts für Virologie aussprechen, allen voran den ehemaligen Mitgliedern der Mandl-
Gruppe: Verena, Blaimi, Katrin, Sabrina, Gabriel, Klaus und Regina. Vielen Dank für die äußerst 
produktive und angenehme Atmosphäre am Institut, die erforderliche Einschulung und Unterstützung 
im Labor und die unterhaltsamen Stunden, in denen wir im „Steindl‘s“ auf den Einsatz des 
Schnitzelklopfers gewartet haben. Danke auch an meine Freunde, die stets für nötige Abwechslung 
sorgten und die mich das Leben auch aus ganz anderen Perspektiven sehen lassen. Spezieller Dank 
gebührt natürlich meiner Freundin Steffi, die in all der Zeit die perfekte Partnerin zum Teilen aller 
Hoch- und Tiefpunkte war, sich unbeirrt von mir erklären ließ, was ich den ganzen Tag so tue und 
deren Unterstützung mir in jeder Hinsicht sicher war. Mein größter Dank gilt meinen Eltern, die mir 
meine Ausbildung ermöglicht haben, sowie meiner gesamten Familie, die in all den Jahren immer für 
mich da war und wohl nie die Hoffnung aufgeben wird, dass ich eines Tages „etwas finden werde“… 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   Content 
SUMMARY   .............................................................................................................................................. 7
ZUSAMMENFASSUNG   .......................................................................................................................... 9
1 GENERAL INTRODUCTION   ........................................................................................................ 11
1.1 FLAVIVIRIDAE   ........................................................................................................................... 11
1.1.1 Classification and taxonomy   .............................................................................................. 11
1.1.2 Epidemiology and disease   ................................................................................................. 12
1.1.2.1 West Nile virus   ........................................................................................................... 12
1.1.2.2 Dengue virus   .............................................................................................................. 13
1.1.2.3 Japanese encephalitis virus   ...................................................................................... 14
1.1.2.4 Yellow fever virus  ....................................................................................................... 15
1.1.2.5 Tick-borne encephalitis virus   ..................................................................................... 15
1.1.3 Molecular organization of flaviviruses   ............................................................................... 16
1.1.3.1 Virion structure   ........................................................................................................... 16
1.1.3.2 Genome structure   ...................................................................................................... 17
1.1.4 The flavivirus life cycle   ....................................................................................................... 18
1.1.5 Conserved RNA motifs involved in RNA replication and translation   ................................. 20
1.1.5.1 The 5’-NCR   ................................................................................................................ 20
1.1.5.2 Long-range interactions and cyclization sequences   .................................................. 21
1.1.5.3 The role of conserved hairpin elements in flavivirus translation initiation   ................. 23
1.1.5.4 The  3’-noncoding region of tick-borne encephalitis virus   ......................................... 23
1.2 SMALL SILENCING RNAS   .......................................................................................................... 25
1.2.1 Classes of small silencing RNAs   ....................................................................................... 25
1.2.2 RNA interference (RNAi)   ................................................................................................... 26
1.2.2.1 History and mechanism of RNAi   ................................................................................ 26
1.2.2.2 RNAi – an intrinsic antiviral defense mechanism in mammals?   ................................ 27
1.2.3 MicroRNAs   ......................................................................................................................... 29
1.2.3.1 Biogenesis of microRNAs   .......................................................................................... 29
1.2.3.1.1 The canonical (linear) pathway of microRNA processing  ...................................... 29
  
1.2.3.1.2 The mirtron pathway   .............................................................................................. 31
1.2.3.2 Biological roles of microRNAs   ................................................................................... 32
1.2.3.3 MicroRNAs in virus-host interactions  ......................................................................... 32
1.2.3.4 MicroRNA-122 and hepatitis C virus – exceptions prove the rule   ............................. 35
1.2.3.5 Epstein-Barr virus microRNA-BART2   ........................................................................ 36
2 AIMS   .............................................................................................................................................. 37
3 MANUSCRIPT 1   ............................................................................................................................ 39
"Analysis of the effects of alterations in the tick-borne encephalitis virus  
3'-noncoding region on translation and RNA replication using reporter replicons" 
4 MANUSCRIPT 2   ............................................................................................................................ 53
"Functional microRNA generated from a cytoplasmic RNA virus" 
5 MANUSCRIPT 3   ............................................................................................................................ 81
"Mutational analysis of three tick-borne encephalitis virus 5'-proximal stem-loop 
structures indicates different roles in RNA replication and translation" 
6 REFERENCES   ............................................................................................................................ 105
7 CURRICULUM VITAE   ................................................................................................................. 115
 
 
 
 
 
 
 
 
 
 
 
S u m m a r y  | 7 
 
SUMMARY 
 
 Flaviviruses are small enveloped viruses with a positive-stranded RNA genome that 
include important human pathogens such as Dengue virus, yellow fever virus and tick-borne 
encephalitis virus. The epidemiology of these viruses is largely determined by the ecological 
needs of the corresponding insect vectors, i.e. mosquitoes or ticks. The disease patterns they 
evoke range from mild febrile illness, to encephalitis and hemorrhagic fever.  
 The genome of all flaviviruses consists of a single RNA molecule that per se acts as an 
infectious messenger RNA and contains the coding sequence for the viral polyprotein. The single 
open reading frame is flanked by noncoding regions (NCRs) that reside on the terminal ends of 
the viral RNA strand and occupy important functions in RNA translation, replication and possibly 
also packaging. Compared to the protein-coding region, the noncoding regions are not well 
conserved between mosquito- and tick-borne flaviviruses.  
The main objective of this thesis was the characterization of endogenous as well as 
heterologous sequence elements in the genome of tick-borne encephalitis virus (TBEV). The 
unique tick-borne encephalitis 3’-NCR is divided into a highly conserved core region, which 
comprises essential secondary structures that are involved in RNA replication, and a variable 
region of inconsistent length that completely lacks sequence conservation. The function of the 
variable region that is characterized by a poly-A stretch in some but not all TBEV strains is 
essentially unknown. 
 In our first approach we addressed the question whether the variable part of the 3’-NCR 
region has any effect on the efficiency of RNA replication or RNA translation. For this purpose we 
analyzed the impact of various manipulations of the 3’-NCR in a sensitive luciferase-based 
reporter replicon system. Our results revealed that truncation or complete removal of the poly-A 
stretch or even the deletion of the entire variable region does not cause a significant effect on any 
of these processes. Furthermore we observed that the replacement of the variable region with 
heterologous sequence elements was well tolerated during RNA replication and did not impair 
viral input RNA translation. These findings provided the basis for our second study in which we 
examined the capability of tick-borne encephalitis virus to encode functional microRNAs. 
 MicroRNAs are a class of small noncoding RNAs that have essential regulatory functions 
in eukaryotic gene expression by mediating the sequence-specific translational inhibition or 
degradation of mRNAs. Although DNA viruses have recently been shown to encode and exploit 
their own microRNAs in the complex interactions with their mammalian host cells, no such 
molecules have so far been identified from viruses with an RNA genome and a cytoplasmic 
replication cycle. Based on the current understanding that microRNA biogenesis is initiated in the 
nucleus and characterized by an RNA cleavage event, it is generally reasoned that this pathway 
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is not available and unusable for viruses that are confined to the cytoplasm and comprise an RNA 
genome. We addressed this issue experimentally and introduced a heterologous herpesvirus 
microRNA-precursor element into the TBEV 3’-NCR. In the subsequent characterization of this 
chimeric virus we were able to demonstrate for the first time that a functional microRNA can 
indeed be produced from such a virus without an impairment of viral RNA replication.  
 Additional studies of this thesis concentrated on the conserved RNA secondary structure 
elements in the 5’-NCR of TBEV. Recently the 5’-part of the TBEV cyclization sequence has been 
mapped to one of these motifs. To further determine the role of this and other hairpin elements 
we performed a mutational analysis in our luciferase-reporter system and screened for defects in 
viral RNA replication and translation. This approach also included the manipulation of the 
thermodynamic stability of these elements and revealed several new insights into the functional 
importance of the TBEV 5’-terminal stem-loop structures.  
 Taken together the results of this thesis extend the current knowledge on endogenous 
genetic RNA elements of TBEV, contribute to the inceptive understanding of the complex 
interplay of RNA viruses with the RNA silencing machinery, and also provide a rational basis for 
RNA virus vector design. 
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ZUSAMMENFASSUNG  
 
 Flaviviren sind kleine lipidumhüllte Viren mit einem positiv-strängigen RNA Genom, denen 
eine Reihe von humanpathogenen Krankheitserregern, wie das Dengue-Virus, das Gelbfieber-
Virus und das FSME (Frühsommer-Meningoencephalitis)-Virus angehören. Die Epidemiologie 
dieser Viren wird weitestgehend durch die ökologischen Anforderungen ihrer Insektenvektoren 
(Stechmücken oder Zecken) bestimmt und die Krankheitsbilder, die sie hervorrufen, reichen von 
milden, fieberhaften Symptomen über Hirnhautentzündung bis hin zu hämorrhagischem Fieber.  
 Das Genom aller Flaviviren besteht aus einem einzigen RNA-Molekül, das die kodierende 
Sequenz für das virale Polyprotein enthält und das selbst als infektiöse mRNA fungiert. Der 
einzige offene Leserahmen auf diesem RNA-Molekül ist an den beiden Enden von nicht-
kodierenden Regionen flankiert, die eine entscheidende Rolle in der Translation, der Replikation 
und möglicherweise auch in der Verpackung der Virus-RNA spielen. Verglichen mit den 
kodierenden Sequenzbereichen des Genoms, sind diese nicht-kodierenden Regionen zwischen 
den beiden Hauptgruppen, den Insekten- und den Zecken-übertragenen Flaviviren, allerdings nur 
sehr schwach konserviert.  
 Das Hauptziel der vorliegenden Arbeit war die Charakterisierung von endogenen wie 
auch von heterologen Sequenzelementen im FSME-Virus Genom. Die innerhalb der Flaviviren 
einzigartige, nicht-kodierende Region am 3’-Ende der viralen RNA (3’-NCR) wird in eine hoch 
konservierte „Kernregion“ und eine hinsichtlich ihrer Sequenz flexible „variable Region“ unterteilt. 
Die näher am 3’-Ende liegende „Kernregion“ enthält hoch konservierte RNA-Sekundärstrukturen, 
die unter anderem essentiell für die Virusreplikation sind. Die weiter innen angeordnete „variable“ 
Region differiert stark hinsichtlich ihrer Länge und ist auch zwischen einzelnen Stämmen 
innerhalb der FSME-Virus Familie nicht konserviert. Die Funktion der variablen Region, die in 
manchen FSME-Virus Stämmen durch eine Poly-A Sequenz gekennzeichnet ist, ist im 
Wesentlichen unbekannt.  
 Im ersten Teil dieser Arbeit gingen wir der Frage nach, ob die variable Region in der 3’-
nicht-kodierenden Sequenz des FSME-Virus einen Einfluss auf die Replikation und/oder 
Translation der viralen RNA ausübt. Dazu führten wir Mutationen in diesen Sequenzbereich ein 
und analysierten in einem sensitiven Luziferase-Reporter-Replikon System potentielle Effekte auf 
Translation und Replikation. Unsere Ergebnisse zeigten, dass eine Verkürzung oder Entfernung 
der Poly-A Sequenz, aber auch eine Deletion der gesamten variablen Region, keinen 
signifikanten Effekt auf einen dieser beiden Prozesse ausübt. Darüber hinaus wurde klar, dass 
die variable Region ohne Beeinträchtigung der Translation oder Replikation durch heterologe 
Sequenzelemente ersetzt werden kann. Letztere Erkenntnis lieferte den Grundstein für unser 
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zweites Projekt, in dem wir untersuchten, ob das FSME-Virus in der Lage ist, funktionelle 
microRNAs zu kodieren.  
 MicroRNAs sind eine Klasse von kleinen, nicht-kodierenden RNAs, die essentielle 
regulatorische Funktionen in der eukaryotischen Genexpression innehaben. Sie vermitteln dabei 
die sequenz-spezifische, post-translationale Inhibierung oder den Abbau von mRNAs. Obwohl 
kürzlich gezeigt werden konnte, dass DNA-Viren eigene microRNAs kodieren und diese in der 
Wirtszelle auch zu ihren Gunsten einsetzen können, gibt es keine Berichte über microRNAs von 
Viren mit einem RNA-Genom und einem zytoplasmatischen Lebenszyklus. Dem momentanen 
Wissensstand zufolge beginnt die Biogenese von microRNAs im Zellkern und zeichnet sich dort 
unter anderem durch einen Schnitt im RNA-Molekül aus, der den microRNA Vorläufer für die 
weitere Prozessierung freisetzt. Es wird daher allgemein angenommen, dass dieser Biogenese-
Weg für Viren mit einem RNA-Genom und einem zytoplasmatischen Lebenszyklus weder 
zugänglich noch nutzbar ist. Unser Ziel war es, diese Annahme hinsichtlich ihrer Gültigkeit in 
einem Modellsystem zu überprüfen. Wir klonierten dazu einen heterologen Herpesvirus 
microRNA-Vorläufer in die nicht-kodierende 3’-Region des FSME-Virus. In der nachfolgenden 
Charakterisierung dieser chimären Mutante gelang uns der erstmalige Nachweis, dass eine 
funktionelle microRNA auch von einem zytoplasmatisch replizierenden Virus mit einem RNA-
Genom generiert werden kann, ohne dass das notwendigerweise mit einer signifikanten 
Beeinträchtigung der RNA Replikation einhergehen muss. 
 Im dritten Teil der vorliegenden Arbeit befassten wir uns mit konservierten RNA-
Sekundärstrukturen am 5’-Ende des viralen RNA Moleküls. Kürzlich konnte der 5’-Teil der FSME-
Virus Zyklisierungssequenz einer Haarnadelstruktur in diesem Genombereich zugeordnet 
werden. Um die Rolle dieses und anderer Sequenzelemente hinsichtlich ihrer Funktion zu 
untersuchen, führten wir in unserem Luziferase-Reportersystem eine Mutationsanaylse durch, die 
auch eine gezielte Veränderung der thermodynamischen Stabilität beinhaltete und so neue 
Einblicke in die Wirkungsweisen dieser Elemente in der viralen Replikation und Translation liefern 
konnte.  
 Zusammenfassend lässt sich sagen, dass die Ergebnisse dieser Arbeit den derzeitigen 
Wissensstand über die Funktion endogener RNA-Elemente im Genom des FSME-Virus 
erweitern, dass sie wesentlich zu einem besseren Verständnis der komplexen Interaktion von 
RNA-Viren mit der RNA-Interferenz-Maschinerie der Wirtszelle beitragen, und dass sie darüber 
hinaus eine wertvolle Grundlage für das Design von RNA-Virus Vektoren liefern. 
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1 GENERAL INTRODUCTION 
 
1.1 Flaviviridae 
 
1.1.1 Classification and taxonomy 
 
The family Flaviviridae comprises one of the three superfamilies of positive-stranded 
RNA viruses and is subdivided into three genera: the genus Flavivirus, the genus Pestivirus 
and the genus Hepacivirus. All three genera share common structural features, such as lipid-
enveloped virions with two glycoproteins on its surface  (E, envelope and M, membrane) and 
a positive-stranded RNA genome that forms a nucleocapsid by complexing with multiple 
units of the capsid protein C (1).  
The genus Pestivirus contains several important animal pathogens that primarily 
infect goat, sheep and cattle, and is therefore of significant interest for livestock industry. The 
genus Hepacivirus contains the human hepatitis C virus (HCV) that is one of the major 
reasons for chronic liver disease and hepatocellular carcinomas in humans (1).  
The largest genus Flavivirus consists of more than 70 viruses that are mainly 
transmitted to vertebrates by infected arthropods such as mosquitoes or ticks. Flaviviruses 
can be further subdivided into antigenic complexes, clades and clusters (Fig. 1),(1-3). They 
cause a large spectrum of diseases in humans ranging from asymptomatic infections to 
febrile illness, fatal encephalitis and hemorrhagic fever (1,3).  
The next section provides an overview about the epidemiology and disease of the 
most important human flaviviruses West Nile virus (WNV), Japanese encephalitis virus 
(JEV), yellow fever virus (YFV) and Dengue virus (DENV), all of them mosquito-borne 
flaviviruses, and the tick-transmitted tick-borne encephalitis virus (TBEV).  
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1.1.2 Epidemiology and disease 
 
1.1.2.1 West Nile virus 
Until recently West Nile virus was not considered as an emerging viral pathogen. 
Infections were mainly restricted to rural areas in Africa and Asia and the number of severe 
neurological illnesses remained relatively low (4). This changed when a more virulent strain 
of the virus was introduced into the US in 1999. Since then its geographic distribution has 
expanded remarkably (5),(Fig. 2). Soon WNV has become the leading cause for arboviral 
encephalitis in the United States (6). The virus circulates between various bird species that 
represent the natural reservoir of the virus and the preferred vector, mosquitoes of the genus 
Culex. Humans and other mammals are incidental hosts that do – except from horses – not 
produce a high enough viremia to actively contribute to the transmission cycle (4).  
Approximately 80% of all WNV infections remain asymptomatic, 20% of infected humans 
generate “West Nile fever”, a self limited, febrile illness. In approximately one out of 150 
patients, infection results in severe neurological disease (West Nile neuroinvasive disease), 
including encephalitis, meningitis and acute flaccid paralysis (4). It should be mentioned, 
Figure 1. Flavivirus classification. The genus Flavivirus is subdivided into different serocomplexes, 
clades and clusters, according to antigenic properties, molecular phylogeny and the mode of 
transmission. Adapted from Mukhopadhyay et al., Nature Reviews Microbiology, 2006. 
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however, that case numbers in the US between 2004 and 2007 remained stable and that 
WNV infections might have reached an endemic level that more likely tends to a decline in 
the number of cases rather than to an increase (6). Although several human vaccines are 
currently under development, the only licensed ones are restricted to use in horses (7). 
 
1.1.2.2 Dengue virus 
Dengue virus represents a major health problem in tropical and subtropical regions, 
with a growing global incidence. Approximately two fifths of the world population are currently 
at risk of infection and it is estimated that there are more than 50 million cases per year (8). 
Dengue viruses can be subdivided into 4 serotypes (DENV 1-4) and all of them are 
transmitted to humans through a bite of infected Aedes mosquitoes (9). The outcome ranges 
from an asymptomatic infection or a febrile illness (dengue fever) to severe Dengue, a 
clinical syndrome that is characterized by increased vascular permeability and plasma 
leakage from blood vessels into tissues (Dengue hemorrhagic fever, DHF). This might in the 
Figure 2. Endemic regions of the most important human flaviviruses. Adapted from Klaus 
Orlinger, “Construction and Application of Bicistronic Flaviviruses”, (Ph.D. thesis, University of Vienna, 
2007). 
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worst case cause shock (Dengue shock syndrome, DSS),(10). Although Dengue virus is the 
leading cause of serious illness and death among children in some Asian countries, there is 
currently no vaccine available. One of the reasons for this is that while infection with any of 
the 4 serotypes induces a life-long homotypic immunity, antibodies produced during this 
primary infection may cause a more severe form of the disease (with a higher risk of 
obtaining DHF or DSS) among secondary heterotypic dengue infection. The mechanism 
underlying this phenomenon is most likely antibody-dependent enhancement (ADE), a 
process in which pre-existing subneutralizing antibodies form complexes with the virus, 
which in turn leads to increased uptake of the virus by Fc-receptor bearing cells (11,12).  For 
this reason, the major challenge in the development of a safe and successful Dengue virus 
vaccine is, to find a formulation that provides equal protection against all four serotypes. 
Although the development of such a vaccine is problematic, several multivalent candidate 
vaccines, including live attenuated viruses and chimeric vaccines, have already reached the 
phase of clinical testing (13). 
1.1.2.3 Japanese encephalitis virus 
Japanese encephalitis virus is mainly endemic in Eastern, South-Eastern and 
Southern Asia but it has also caused an epidemic in Australia (14). Like WNV that belongs to 
the same serocomplex of flaviviruses, it is transmitted by Culex mosquitoes that feed on 
humans, pigs, birds and even amphibian and reptiles (10,15). Although humans are only 
incidental hosts and most infections remain subclinical, JEV infection is with more than 
50,000 reported cases annually, the major cause of viral encephalitis in Asia. In a severe 
form the disease can progress to paralysis, seizures, coma and death (16). Several 
inactivated and live attenuated vaccines are in use in Asia but not licensed in Europe or the 
United States. JE-VAX® (Sanofi-Pasteur), an inactivated mouse-brain-derived inactived JE 
vaccine with US-approval, is not manufactured any more. A new cell-culture based inactived 
JE vaccine (IXIARO®), developed by the Austrian biotech company Intercell, successfully 
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launched the market in 2009. This vaccine, however, is not yet licensed for the use in 
children (17).  
1.1.2.4 Yellow fever virus 
The mosquito-borne yellow fever virus is endemic in sub-saharan Africa and in parts 
of Southern America (18). Although YFV is transmitted by the same mosquito-species as 
Dengue virus (Aedes aegypti) it is remarkably less widespread and has never appeared in 
Asia (10). It is estimated that around 200,000 cases occur annually (19). Clinical symptoms 
of YFV infection range from influenza like patterns including headache, backache, muscle 
pain and fever to severe hepatitis (that causes the yellow jaundice), hemorrhagic fever, and 
multisystem-organ failure (20). A YFV strain 17D derived attenuated live virus vaccine is 
efficiently used since decades (20). 
1.1.2.5 Tick-borne encephalitis virus 
Tick-borne encephalitis virus is endemic in many European countries as well as in the 
Far-East and in Asia (Fig. 2). Based on moderate differences in their nucleotide sequences 
and “signatures” on protein level, TBE viruses are grouped into three closely related 
subtypes: a European subtype (including strain Neudoerfl, the prototype strain used 
throughout the studies presented in manuscripts 1-3), a Far-Eastern subtype and a Siberian 
subtype (21). Small rodents are the main host of TBEV, and ticks that can be chronically 
infected act as transmission vectors. Humans, as well as larger animals such as goat, sheep 
and cow are incidental hosts that do only play a minor role in the natural TBEV transmission 
cycle (22). The Central European subtype is transmitted by Ixodes ricinus, whereas the main 
vector for tick-borne encephalitis in Eastern countries is Ixodes persulcatis (23). Tick-bites, 
however, are not the only way of getting infected with the virus. Outbreaks of tick-borne 
encephalitis have also been reported after consumption of unpasteurized milk from viremic 
livestock (22,24). Interestingly, although TBEV can be found in a very large geographical 
area, the sole presence of the corresponding tick-vector does not necessarily imply a 
coincidence with the virus. Ixodes ricinus for instance is widely distributed throughout entire 
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Austria, the virus itself, however, accumulates only at restricted geographic hotspots. The 
micro-ecological specifications that underlie these patchy geographical clustering of suitable 
virus biotypes are largely unknown (25). 
In about 70% of all cases, infection with TBEV remains asymptomatic. In the 
remaining 30% a biphasic febrile illness may follow that can include fever, malaise, anorexia, 
muscle aches, headache, nausea, and/or vomiting. This initial phase lasts about 2-4 days 
and corresponds to the viremic phase of virus infection. In 20 to 30% of patients, a second 
phase may occur that involves the central nervous system. This phase is accompanied by 
symptoms of encephalitis and meningitis and can result in persisting spinal nerve paralysis. 
The mortality rate of patients whose central nervous system is affected is approximately 1-
2% for the European subtype (26,27). Infection with TBEV can effectively be prevented by 
vaccination. Austria, with a current vaccination rate of approximately 90% is a good example 
for the effectiveness of this vaccine: In the pre-vaccination era, 600-700 TBEV infections 
were reported per year which has dropped now to 60-70 annual cases (26,28). Apart from 
Russian vaccines (based on the Far Eastern subtype), two inactivated whole virus vaccines 
are available in Europe that are based on the European subtype: FSME-IMMUNTM, 
manufactured by Baxter (Austria), and EncepurTM, produced from Novartis (Germany),(28). 
 
1.1.3 Molecular organization of flaviviruses 
 
1.1.3.1 Virion structure 
Flavivirus virions are relatively small (~50 nm) particles that are composed of a dense 
core that contains the nucleopcapsid and which is surrounded by a lipid envelope. The 
surface of the mature virion contains two viral structural proteins, the envelope protein (E) 
and the membrane protein (M). Glycoprotein E mediates binding and fusion of the virus and 
is the major antigenic determinant. The M protein is produced during the maturation process 
of the virus by Furin cleavage of the precursor-M (prM) protein. This results in a structural 
rearrangement of the 60 heterotrimeric prM-E glycoproteinspikes into 90 antiparallel 
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homodimers which can be found on the smooth surface of the mature particle (Fig. 3), (1,29). 
The third structural protein of the virus, the capsid protein C, is complexed with the viral RNA 
and forms the nucleocapsid core that does not appear to have a symmetric structure (1). 
 
 
 
 
 
 
 
1.1.3.2 Genome structure 
The genome of flaviviruses is composed of a single positive-stranded RNA molecule 
of about 11 kb length that contains only one open reading frame (Fig. 4). It is infectious when 
introduced into a host cell and can be directly translated into an endoplasmatic reticulum 
(ER) - anchored polyprotein that is cleaved into the 10 viral proteins (three structural 
proteins, C, prM and E that composite the viral particle and seven non-structural proteins, 
NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 that are involved in viral replication). The 
RNA is capped with a 5’-type-I cap but unlike cellular messenger RNAs the 3’-end does not 
Figure 3. Structure of the immature (left) and mature (right) flavivirus particle. Adapted from 
Stiasny and Heinz, Journal of General Virology, 2006. 
Figure 4. Flavivirus genome structure.  
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contain a poly-A tail (1,30). The highly structured 5’- and 3’-noncoding regions of the genome 
contain regulatory elements that are involved in a variety of important viral processes such 
as RNA translation and replication and are treated separately in chapter 1.1.5. 
 
1.1.4 The flavivirus life cycle 
 
After cellular attachment the flavivirus particle is internalized by receptor-mediated 
endocytosis (Fig. 5). The knowledge on flavivirus receptors is still fragmentary but most likely 
flaviviruses are able to use multiple receptors in different cell types and hosts (1). Several 
studies have indicated an involvement of cellular heparansulfate (HS), a highly sulfated 
glycosaminoglycan, on viral attachment and entry (31,32). However, the presence of HS on 
the cellular surface is not mandatory for virus uptake.  
In the endosome the viral particle is exposed to acidic pH that triggers the  
trimerization of the E protein and insertion of the E protein fusion peptide into the endosomal 
membrane (29,33). This results in fusion of the two lipid membranes and subsequent release 
of the viral nucleocapsid into the cytoplasm. Once inside the cytoplasm, the viral RNA and 
the capsid proteins dissociate from each other and the viral RNA is readily translated by the 
host cell translational machinery (3). This occurs at the membrane of the endoplasmatic 
reticulum, where the polyprotein integrates into the ER membrane and is co- and post-
translationally cleaved by the viral NS2B/3 serine protease (cleavages between NS2A/2B, 
NS2B/3, NS3/4A, NS4A/2K and NS4B/5 junctions) and the host signal peptidase (C/prM, 
prM/E, E/NS1 and 2K/NS4B),(1). Initiation of translation occurs by ribosome scanning 
through the genome 5’ end but the strategies for proper selection of the start codon may not 
be uniform for all flaviviruses (see 1.1.5.3).  
Following translation, a replicase complex is assembled for viral RNA amplification. 
First, a minus-strand copy of the genomic positive-strand is synthesized. This is mediated by 
cyclization of the viral genome and does not require a pre-existing RNA primer. The minus-
strand then serves as a template for additional plus-strands in an asymmetric process, that 
G e n e r a l  I n t r o d u c t i o n  | 19 
 
gives rise to around 10-fold more positive- than negative-strands (1).The process of RNA 
replication takes place in double-layered vesicle packets in close association with the 
perinuclear membrane (1,34). The most important viral proteins involved in RNA synthesis 
are the viral RNA-dependent RNA polymerase NS5 (which also functions as a capping 
enzyme) and the NS3 protein that acts in unwinding the double-stranded RNA intermediate 
structure (35).  
The first step in virion assembly is the formation of a nucleocapsid at the cytoplasmic 
site of the ER. The capsid then buds into the ER lumen, where the viral surface proteins prM 
and E are residing as a consequence of polyprotein processing and thus are available for the 
formation of the ER-membrane derived envelope that surrounds the nucleocapsid of a newly 
formed virus particle. The immature prM containing virion is then transported through the 
host cell secretory pathway. PrM cleavage by Furin in the late trans-Golgi network (TGN) 
causes the already mentioned structural rearrangement of the E protein and generates the 
Figure 5. The flavivirus life cycle. See text for details. Modified from Stiasny and Heinz, Journal of                                                                                         
General Virology, 2006. 
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mature, infectious virus particle that is ultimately released from the cell by fusion of the Golgi 
vesicle with the host cell plasma membrane (29,36,37). 
 
1.1.5 Conserved RNA motifs involved in RNA replication and translation 
 
The genome of flaviviruses contains RNA secondary structure elements that 
contribute to the overall RNA stability but also mediate essential inter- and intramolecular 
interactions for initiation of RNA replication and translation or for the interaction of the viral 
RNA with cellular proteins that facilitate or regulate such processes (38,39). The majority of 
those cis-acting RNA elements are located within or in close proximity to the noncoding 
regions at the terminal ends of the viral genome. 
This section treats elements that are involved in translation and replication of the viral 
RNA and points out significant differences between tick-borne and mosquito-borne 
flaviviruses. 
1.1.5.1 The 5’-NCR 
The flavivirus 5’-NCR is relatively short (approximately 100 nt in length) and generally 
not very well conserved between different members of the genus. Mosquito-borne 
flaviviruses tend to have even shorter 5’-NCRs than tick-borne viruses (132 nt for TBEV 
strain Neudoerfl, 96 nt for WNV strain NY99).  
As already mentioned, translation initiation of flavivirus RNA occurs in a cap-
dependent mechanism (40), comparable to the mechanism for cellular mRNAs. In contrast to 
some other positive-stranded RNA viruses that lack a 5’-cap (e.g. polioviruses), there is 
therefore no need for a longer, more complex RNA secondary structure that could act as an 
internal ribosomal entry site (IRES),(41). The most conserved linear sequence feature that is 
present in all flavivirus genomes (except Cell fusing agent, CFA) is the 5’-terminal 
dinucleotide 5’-AG which exhibits perfect complementarity to the equally conserved 3’-
terminal end of the genome (CU-3’) and is engaged in long range interaction between the 
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terminal ends of the viral RNA molecule (30,41,42). In addition several conserved secondary 
structures are predicted in the genomes of tick-borne as well as mosquito-borne flaviviruses 
(Fig. 6). A common element is a large Y-shaped structure (43) at the 5’ terminal end of the 
genome (termed 5’-SL1 for tick-borne flaviviruses and SLA for mosquito-borne viruses) that 
is of significant importance for viral RNA replication (44) and RNA capping (45), and that has 
been proposed to act as promoter for negative-strand RNA synthesis (46,47).  
Downstream of the 5’-SL1 (or SLA, respectively), additional conserved stem-loop 
elements have been described. For mosquito-borne flaviviruses these are a smaller hairpin 
(SLB) that is located at or close to the translational start codon and a conserved small hairpin 
in the capsid coding region (cHP). In tick-borne encephalitis virus, three additional hairpins 
have been predicted: the 5’-SL2, the 5’-SL3 and the 5’-SL4 (Fig. 6A). The role of these 
hairpins in viral input RNA translation and replication was subject to analysis in manuscript 3 
of this thesis. 
1.1.5.2 Long-range interactions and cyclization sequences 
One function of the conserved viral 5’-end is the mediation of long-range interactions 
with the 3’-end of the viral genome. This has been shown to be essential for viral replication 
(48) and supports the idea that the promoter for minus-strand synthesis is located at the 5’-
end of the positive-strand. As minus-strand RNA synthesis starts at the 3’-end of the positive-
strand, the 5’- and the 3’-end of the genome have to be brought into close proximity. This is 
accomplished by sequence complementarity between the genomic ends of the viral RNA 
molecule that enable a structural rearrangement and a switch from a linear into a circular 
conformation (a panhandle-like structure).  
 Although genome cyclization is thought to be mandatory for all flaviviruses, 
differences exist in the genomic regions that participate in this process. In the case of tick-
borne encephalitis virus, a 5’-CS-A element located within the 5’-SL2 binds to a 
corresponding 3’-CS-A element in the terminal stem-loop 3’-SL1 (see green line in              
Fig. 6A),(48,49). A second long-range interaction that has been predicted between the 5’-
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SL4 and the region between the terminal stem-loops 3’-SL5 and 3’-SL4 (50) has shown to be 
dispensable for viral RNA replication (49). In contrast, two pairs of long-range interactions 
have been proposed to be important for the replication of mosquito-borne flaviviruses. The 
5’-3’-UAR (upstream AUG region) interaction (51) mediated by complementary parts of SLB 
and 3’-SL, respectively (Fig 6B, red line) and the complementarity between the 5’-3’-CS 
elements, located within the coding sequence of the capsid protein in the 5’-end and in the 
3’-NCR of the viral 3’-end (Fig. 6B, blue line),(50,52,53). 
Figure 6. Conserved secondary structures in the 5’- and 3’-noncoding regions of tick-borne 
(e.g. TBEV) and mosquito-borne (e.g. DENV) flaviviruses. Long-range interactions are indicated by 
coloured lines. Panel B modified from Villordo and Gamarnik, Virus Research, 2009.  
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1.1.5.3 The role of conserved hairpin elements in flavivirus translation initiation 
In addition to their prominent role in viral RNA replication some of the conserved 
stem-loop elements at the 5’-end of the viral RNA molecule might also function in translation 
initiation. Cap-dependent translation requires the eukaryotic translation initiation factor 4E, a 
component of the cap-binding complex eIF4F. Nevertheless a novel non-canonical 
translation initiation mechanism that does not require the cap-binding protein 4E, has been 
recently described  for Dengue virus (54). It was shown that the conserved, 
thermodynamically stable hairpin structure element cHP in the capsid coding region (Fig. 6B) 
is able to direct translational start site selection when cap-dependent translation is inhibited 
(54,55). The proposed mechanism is that the translation complex stalls due to the unwinding 
of the secondary structure of the cHP and thereby interacts with the first AUG codon (55). As 
the start codon of Dengue virus is in a poor Kozak inititation context (meaning that the 
efficiency of the codon is low due to the sequence composition of the immediate upstream 
and downstream region (56)), it is likely that the cHP directs start codon selection even in the 
presence of 4E. This is in good agreement with a previous report in which it was shown that 
the insertion of a stable secondary structure element downstream of an AUG codon in a poor 
Kozak initiation context can enhance the selection of this codon for translation initiation 
(55,57).  
The situation for tick-borne encephalitis virus is largely unknown. Although the 
translational start codon is embedded in a strong Kozak initiation context, a 
thermodynamically stable, conserved hairpin structure element is predicted to be maintained 
in the N-terminal end of the capsid coding region (5’-SL4). Whether the TBEV 5’-SL4 has a 
similar function in viral RNA translation as the cHP element in mosquito-borne flaviviruses 
was subject to analysis in manuscript 3. 
1.1.5.4 The 3’-noncoding region of tick-borne encephalitis virus 
Although the 3’-NCRs of mosquito- and tick-borne flaviviruses are functionally related, 
the structural organization of the tick-borne encephalitis virus 3’-NCR is substantially different 
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from the one of mosquito-borne flaviviruses. Similarities are mainly confined to the presence 
of a characteristic 3’-terminal stem-loop structure (3’-SL1 for tick-borne viruses and 3’-SL for 
mosquito-borne flaviviruses) that mediates the interaction with the viral NS3 and NS5 
proteins and contributes to genome cyclization, replication and translation (1). Another 
common feature has been discovered only recently: All flaviviruses produce a highly 
structured, subgenomic RNA that is derived from the 3’-NCR and apparently required for viral 
pathogenicity (58).  
The tick-borne encephalitis virus 3’-NCR is subdivided into a highly conserved, 325 nt 
long core region at the 3’-terminal end of the virus and a non conserved variable region 
upstream of the core region, ranging from 450 to 800 nts in length in natural isolates (41,59). 
Interestingly, the variable region of some isolates has been shown to contain an internal 
poly-A stretch of inconsistent length (60) (49 nts for strain Neudoerfl) that is sometimes 
spontaneously deleted or further elongated during viral passaging (61). The core region 
comprises the essential sequence elements that are involved in genome cyclization and RNA 
replication (49,59,61,62) and appears to be sufficient for a viable TBE virus (41). TBEV strain 
RK1424 for instance does virtually not contain a variable region (41). Furthermore it has 
been demonstrated that removal of the variable region does not abolish viral infectivity of 
TBEV strain Neudoerfl (61) and that the variable region can be replaced by heterologous 
genetic information (63-66).  
In manuscript 1 we performed a functional analysis of the variable region of the TBEV 
3’-NCR by sensitive measurement of primary translation and RNA replication in a luciferase-
based replicon assay and further replaced this region with heterologous expression 
cassettes. In manuscript 2 we extended the variable region with the microRNA-precursor 
element of a herpesvirus.  
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1.2 Small silencing RNAs 
 
In 1993, the first small silencing RNA, the lin-4 microRNA, was discovered in the 
nematode worm Caenorhabditis elegans (67,68). Since then, thousands of tiny non-protein-
coding (nc) RNAs have been found and shown to be involved in almost all physiological 
processes in eukaryotic cells by mediating post-transcriptional silencing of gene expression. 
All of these tiny regulatory RNAs share common themes in their biology, such as their limited 
size (~20-30 nucleotides) and their association with Argonaute (Ago-) family proteins, 
catalytic components of the RNA-induced silencing complex (RISC). This section aims to 
provide an overview about different classes of small silencing RNAs, summarizes briefly our 
current knowledge on RNA interference (RNAi) and its role in antiviral defense, and focuses 
in more detail on microRNAs and their role in animal virus infection. 
 
1.2.1 Classes of small silencing RNAs  
 
Based on the mechanism of their biogenesis and the class of Ago proteins they are 
associated with, small silencing can be grouped into three different classes: microRNAs 
(miRNAs), small interfering RNAs (siRNAs) and Piwi-interacting RNAs (piRNAs),(69,70). 
However, as it is becoming clear since recently that numerous small RNAs are products of 
non-canonical pathways, the boundaries between these different classes of small RNAs in 
animals are ambiguous (69). 
MicroRNAs are the best characterized small silencing RNAs and their biogenesis and 
biological roles are described in more detail in section 1.2.3. SiRNAs are the effector 
molecules of RNA interference, which is discussed in more detail below. PiRNAs were 
recently discovered in germ cells of Drosophila and have been proposed to be important 
regulators of cellular development (71). Piwi-proteins are a subclass of Argonaute proteins 
and have been shown to be essential in germ line stem cells. Compared to microRNAs and 
siRNAs, piRNAs are longer in size (24-29 nt). Most of them are derived from intergenic 
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repetitive elements on chromosomes, including retrotransposons (69). The biogenesis of 
piRNAs is not well elucidated. It has been shown, however, that in contrast to siRNAs and 
miRNAs their production is not necessarily dependent on Dicer (72).  The most important 
biological function of piRNAs is the silencing of “selfish” retrotransposons in germ cells, an 
essential process that has been linked to spermatogenesis (73). 
 
1.2.2 RNA interference (RNAi) 
 
1.2.2.1 History and mechanism of RNAi 
RNA interference is an evolutionary conserved, highly efficient pathway in which short 
double-stranded (ds) RNA molecules specifically trigger the inhibition of gene expression 
(74,75). RNAi is one of the most powerful technologies in modern biology and it remarkably 
facilitates the study of gene function as it allows the specific depletion of protein-coding 
mRNAs. First hints of the existence for an RNA interference pathway came from experiments 
in plants, when Napoli et al. tried to increase the purple colour of petunias in 1990. 
Unexpectedly, the introduction of additional gene copies encoding the coloration key enzyme 
chalcone synthase (CHS), did not result in darker pigmentation but instead yielded partially 
or fully white flowers (76). Related observations were also made in the fungus Neurospora 
crassa, where the introduction of the par-1 RNA resulted in the silencing of the par-1 gene 
expression (77). A few years later virologists found that plants carrying virus-derived non 
protein-coding transgenes, were protected from infection of viruses containing similar 
nucleotide sequences (78). Furthermore it was shown in a reverse experiment that the 
expression of plant genes can be suppressed by infection with a virus, containing parts of the 
plant gene nucleotide sequence (79).  
At this time the introduction of antisense RNAs for gene silencing has already 
become a popular method to study gene function but it took three more years until the 
mechanistic trigger behind this phenomenon was ultimately elucidated. Finally, in 1998, 
Craig Mello and Andrew Fire found that dsRNA was substantially more effective at producing 
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interference that was either strand individually (80). Thereby they demonstrated that the 
trigger for the antisense-RNA effects was double-stranded RNA.  
Initially RNAi was prevented from being applied in mammalian cells, since the used 
dsRNA were longer than 30 nts and thus potent inducers of the interferon system, present in 
higher organisms (74). Just a few years later in 2001, however, the lab of Thomas Tuschl 
reported that RNAi can also efficiently be triggered in mammalians cells by introducing only 
~21 nt long RNA duplexes, that evade a stimulation of the innate immune reponse. These 
short dsRNAs were called small interfering RNAs (siRNAs),(81-83) and are still one of the 
most attractive means in the induction of post-transcriptional gene silencing. For their 
landmark discovery of RNAi  that opened a new chapter in life-science research, Mello and 
Fire were awarded with the Nobel Prize in 2006. 
 
1.2.2.2 RNAi – an intrinsic antiviral defense mechanism in mammals? 
There is strong evidence for a natural, antiviral role of RNAi in plants and 
invertebrates (84-86). In these organisms, viral double-stranded RNA that is produced as an 
essential replication intermediate from all RNA viruses (except from retroviruses) is 
recognized by RNAse III enzymes of the Dicer family and processed into small interfering 
RNAs (87). Single strands of these siRNAs are then incorporated into the RNA induced 
silencing complex, where they guide the degradation of complementary viral mRNA 
sequences (88). The importance of RNA interference as defence mechanism in these 
organisms has been further supported by the discovery of a variety of counter-defence 
strategies that have been evolved from viruses to avert or diminish the effect of this pathway 
on viral pathogenesis.  
The expression of effective silencing suppressors from insect and plant viruses was 
first shown for Flock-house virus (FHV), a member of the genus Alpha-nodavirus. The FHV 
B2-protein is essential for viral infection of insect cells (89) and has a dual role: it inhibits 
Dicer cleavage by binding to the dsRNA and also prevents the incorporation of already 
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cleaved viral RNAs into RISC (90-92). Thereby it enables FHV to accumulate effectively in 
infected insect cells (89).   
So while it is well established that RNAi has an instrumental role in natural viral 
defense in plants and invertebrates, the contribution of RNAi to natural innate defense in 
mammals is less clear. The invasion of RNA viruses in vertebrates is handled differently: 
Three types of pattern recognition receptors (PRRs) sense double-stranded viral RNA: Toll-
like receptors (TLRs), RIG-I like receptors (RLRs) and nucleotide oligomerization domain-like 
receptors (NLRs),(93). The primary reaction to viral dsRNA is the activation of cytokine 
expression and the induction of a type-I interferon response. As a consequence, the binding 
of type-I IFNs to the corresponding receptors (IFNARs) leads to the expression of more than 
300 IFN-stimulated genes (ISGs), which cause a so-called antiviral state and – in an 
amplification loop - a further increase in pattern-recognition receptors that detect virus 
infection and protect from viral spread (94,95).   
Without any doubt, IFNs constitute a key component of the first line of defense 
against viral infection in mammals. This is further underlined by the fact that defects in 
interferon signaling lead to increased susceptibility to virus infection, that interferon therapy 
can successfully be used for the treatment of viral infection and, finally, that many 
mammalian viruses have evolved potent suppressors of the IFN pathway (93,94,96-98). The 
general understanding is therefore that the potent dsRNA-activated antiviral interferon 
system has replaced an antiviral function of the RNAi response and that RNAi interference is 
not involved in the intrinsic antiviral immunity in mammalian cells (99-101). The finding that 
induced RNAi by siRNAs or short hairpin RNAs (shRNAs) is able to trigger sequence specific 
inhibition of viral replication also in mammals (102), can be explained by the fact, that the 
molecules used in triggered RNAi (short dsRNA duplexes or short hairpin RNAs) mimic 
microRNA duplex intermediates of the natural microRNA biogenesis pathway,  which is 
conserved all the way from plants, to invertebrates and mammals (99).  
Nevertheless this black and white picture is becoming increasingly disputed. It has 
been shown for example that many IFN antagonists that are encoded by mammalian viruses 
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(e.g. vaccinia virus E3L, influenza A virus NS1 and Ebola virus VP35) also represent 
effective RNA-silencing suppressors (RSS) and a very recent study found virus-derived small 
RNAs in the size of siRNAs in mammalian cells infected with various RNA viruses (103). 
Whether these molecules are the product of an active RNAi response, however, remains to 
be clarified and thus the question whether siRNAs contribute to antiviral immunity in 
mammalian cells cannot be answered yet. 
 
1.2.3 MicroRNAs 
 
1.2.3.1 Biogenesis of microRNAs 
Until very recently it was thought that microRNA generation is a universal process for 
all mature mammalian miRNAs. However, in addition to the canonical microRNA processing 
pathway (Fig. 7), pathways have been discovered that do not follow the classical cascade to 
generate functional microRNAs in animals. The major, canonical (linear) and the best 
characterized, non-canonical pathway, the so-called mirtron pathway, are described below.  
 
1.2.3.1.1 The canonical (linear) pathway of microRNA processing 
Typically microRNA biogenesis starts with the synthesis of a primary microRNA 
transcript in the nucleus by RNA polymerase II or III (104-107). Many microRNA genes are 
located in introns of mRNAs but some have also been shown to be derived from protein 
coding regions (108). Mostly, these transcripts are capped and polyadenylated and consist of 
an imperfectly paired stem of approximately 33 bp, with a terminal loop and single-stranded 
flanking segments (109-111). Two sequential cleavage steps are then exerted that trim this 
transcript into the mature microRNA. First, Drosha, a RNAse III enzyme located in the 
nucleus, recognizes the local hairpin structure and cleaves at the base of the stem-loop. This 
releases a small hairpin that is called precursor-miRNA (pre-miRNA),(105,112). The 
catalyzation of this cleavage event also requires the activity of a co-factor, the DiGeorge 
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syndrome critical region gene 8 (DGCR8),(113). Together Drosha and DGCR8 form the so-
called microprocessor complex (114-116). The nuclear export protein Exportin-5 then 
mediates the transport of the pre-miRNA to the cytoplasm (117), where a second cleavage 
step is performed by the RNAse III enzyme Dicer and its partner protein TRBP (Dicer and 
TAR RNA binding protein),(118-120). The enzymatic activity of Dicer and TRBP removes the 
terminal loop from the pre-miR-stem and gives rise to a microRNA duplex intermediate of 
approximately 22 bp length that correlates to the two sides of the stem (109). These two 
sides correspond to the guide- and the passenger-strand of an siRNA duplex and similar 
criteria influence the choice of the guide miRNA-strand versus the passenger miRNA-strand 
Figure 7. The canonical microRNA processing pathway. A primary microRNA is transcribed in the 
nucleus and cleaved by Drosha/DGCR8 into a precursor-miRNA that is transported to  the cytoplasm 
by Exportin-5. In the cytoplasm, Dicer exerts a second cleavage step that finally gives rise to a mature 
microRNA that is loaded into the RNA-induced silencing complex (RISC) to guide mRNA target 
cleavage, translational repression or mRNA deadenylation. Adapted from Winter et al., Nature Cell 
Biology, 2009. 
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(121,122). The mature microRNA can therefore theoretically arise from either arm of the 
precursor-microRNA hairpin. In many cases, however, the ratio of microRNAs originated 
from the 5’- and the 3’-arm respectively, is asymmetric, favoring the incorporation of only one 
strand into RISC (70). 
1.2.3.1.2 The mirtron pathway 
Microprocessor mediated cleavage is not the only way to generate mammalian 
precursor-miRNAs. Recently it has been reported that pre-miR can also be generated by the 
nuclear splicing machinery, independent of Drosha cleavage (123-125), (Fig. 8). Such 
precursor-miRNA-like introns (mirtrons) are produced by splicing messenger RNA 
precursors. The spliced introns first accumulate as lariat products and subsequent 
debranching of these structures yields authentic microRNA precursors that can be fed into 
the standard microRNA biogenesis pathway (70). 
Figure 8. The mirtron pathway. In the mirtron pathway Drosha cleavage is bypassed. MicroRNA 
precursors are released from mRNAs after splicing. This requires the splicing machinery and a lariat 
debranching enzyme that forms the hairpin, resembling a precursor miRNA. Further processing is 
then following the classical microRNA biogenesis pathway. Adapted from Ruby et al., Nature, 2007. 
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1.2.3.2 Biological roles of microRNAs 
MicroRNAs have been implicated in almost all biological processes examined so far 
and it soon became clear that they have an essential role in the biology of animals and 
plants. More than 850 microRNAs have so far been identified alone in humans and it is 
predicted that at least 30% of all human mRNAs are regulated by microRNAs (126,127). 
Undisputedly they play a central role in cell metabolism, differentiation and apoptosis. Loss of 
Dicer or miRNA-associated Argonaute proteins is almost always lethal in animals as it 
causes severe developmental defects. Mice lacking Dicer, for instance, die as early embryos, 
most likely due to a defect in stem cell development (70). In addition, dysregulation of 
microRNA expression can also contribute to disease development. Several examples of 
important oncogenic and tumor suppressor miRNAs have been reported  and several studies 
revealed that miRNA signatures in different cell types and tissues have a high diagnostic 
value and may become valuable tools in the clinical therapy of cancer (127). Further 
implications of miRNAs in disease development have been reported in Alzheimer’s disease, 
Parkinson’s disease and heart diseases (127-130). The effects of microRNAs are therefore 
extremely wide-spread. They represent an essential class of gene regulators with a huge 
impact but our knowledge of their precise, multiple functions in eukaryotic cell systems is still 
in its infancy. Clearly, one of the main challenges on the way to a more accurate 
understanding of their biological roles in health and disease is a more precise approach for 
microRNA target prediction. Currently the number of newly discovered microRNAs is 
exploding, whereas the number of those, with known targets and functions remains relatively 
low. 
1.2.3.3 MicroRNAs in virus-host interactions 
Considering the small size of microRNAs and their lack of immunogenicity, it is not 
surprising that these molecules have also been exploited by mammalian viruses as effective 
regulators of gene expression. Potential mechanisms of such virus-host microRNA 
interactions include (I) the targeting of viral transcripts by virally encoded miRNAs, (II) viral 
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microRNAs that target host cell transcripts and (III) cellular microRNAs that directly or 
indirectly promote or potentially also limit virus replication (131),(Fig. 9).  
 
 
 
 
 
The first virus-encoded microRNAs were discovered in 2004, in human B cells 
infected with Epstein-Barr virus (132).  Up to now all herpesviruses examined so far have 
been shown to encode microRNAs (101). In addition, virus-derived microRNAs have been 
found in cells infected with the human adenovirus, Heliothis virescens ascovirus (HvAc) and 
several polyomaviruses (101). Currently known microRNAs are summarized in Table 1. 
Notably, this list does not contain human immunodeficiency virus 1 (HIV-1) derived 
microRNAs that have been proposed by several groups (133-135). The existence of these 
microRNAs could not be confirmed by other groups and is therefore heavily disputed 
(101,136,137). At miR-Base, HIV-1 derived miRNAs are currently listed with subject to be “at 
risk of deletion” (126). So, up to now all viral microRNAs that have been discovered so far 
Figure 9. MicroRNAs in virus-host interactions. (a) Viral microRNAs may inhibit viral mRNA 
expression (e.g. EBV-miR-BART2), (b) viral microRNAs may inhibit the expression of genes in the 
host cell (e.g. KSHV-miR-K12-11) or (c) host cell microRNAs may interfere with viral gene expression  
(this interference may also have positive effects on viral replication - see section 1.2.3.4).  Adapted 
from Cullen, Nature Reviews Genetics, 2006. 
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are derived from dsDNA viruses or – if HIV is to included into the list of miRNA encoding 
viruses, from viruses that involve a nuclear dsDNA stage in their replication cycle. All 
approaches to identify viral microRNAs derived from RNA viruses came so far up empty-
handed. The most  comprehensive small-RNA cloning study that identified numerous new 
microRNAs of the herpesvirus-family did not lead to the identification of any microRNAs in 
cells infected with HCV, YFV and HIV-1 (137).  
It is therefore generally assumed that viruses with an RNA genome and/or a cytoplasmic 
replication cycle are not able to encode microRNAs and that they lack this class of regulatory 
molecules. This conclusion is also supported by two theoretical barriers that arise from the 
life cycle of such viruses and the microRNA biogenesis pathway. First of all, microRNA 
biogenesis is initiated in the nucleus (with the excision of a precursor-miRNA hairpin from a 
primary miRNA transcript by Drosha). So even if such a virus that replicates in the cytoplasm 
of an infected cell encoded a microRNA hairpin, the separation from the microprocessor 
complex in the nucleus may not allow the processing of this hairpin (138). Secondly, even if 
there is a way to liberate the genomically encoded miRNA hairpin, the excision is expected to 
Table 1. Summary of currently known viral microRNAs. Adapted from Umbach and Cullen, Genes 
and Development, 2009. 
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result in cleavage and degradation of the viral genome (131), which is as a consequence 
expected to impair viral RNA replication. Interestingly, however, the lack of experimental 
identification of RNA virus microRNAs is not directly reflected by the outcome of 
computational microRNA hairpin predictions. The viral microRNA database (Vir-mir db) for 
instance that provided the first large scale microRNA prediction in viral genomes, revealed a 
high number of candidate hairpins also in RNA virus genomes (139).   
In manuscript 2 we addressed the question whether there is a fundamental 
incapability of RNA viruses to produce functional microRNAs. We used a model system, in 
which we inserted a known microRNA precursor into the genome of a cytoplasmic RNA virus 
and we were able to show for the first time that there is no fundamental barrier for RNA 
viruses to generate these molecules. 
1.2.3.4 MicroRNA-122 and hepatitis C virus – exceptions prove the rule 
MicroRNA binding to an mRNA does not necessarily lead to mRNA degradation or 
translational inhibition. One striking example for a positive effect, exerted by a cellular 
microRNA on viral gene expression, is the interaction of the human microRNA-122 with the 
RNA genome of hepatitis C virus. MiR-122 is a highly liver-specific microRNA and it accounts 
for approximately 70% of the microRNA repertoire in liver cells, where it regulates fatty acid 
and cholesterol biosynthesis (140-142). The importance of miR-122 for HCV was 
demonstrated by Jopling et al., who reported that the inhibition of miR-122 impairs RNA 
replication of the virus (142). Furthermore it was shown that the binding site of miR-122 is 
highly conserved in all 6 HCV genotypes, which is a strong indication of the relevant role of 
this microRNA in vivo and, as microRNA-122 is exclusively expressed in the liver, also 
compelling evidence for the contribution of microRNA-122 to the tissue tropism of HCV 
(131,142). Two adjacent binding sites for this microRNA have been identified in the 5’-UTR 
of HCV. However, the exact mechanism how this small RNA facilitates virus replication 
and/or translation has yet to be elucidated (101,142,143).  
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1.2.3.5 Epstein-Barr virus microRNA-BART2 
One of the best characterized viral microRNAs is microRNA-BART2, expressed from 
Epstein-Barr virus (EBV). It was identified together with several other microRNAs derived 
from the same virus by cloning the small RNAs from a Burkitt’s lymphoma cell line latently 
infected with EBV (132). In total, EBV encodes at least 23 microRNAs. The B95.8 strain (Fig. 
10) has a deletion of 12 kb and encodes only 8 microRNA genes (144).  
MiR-BART2 is encoded in the BART (Bam HI-A region rightward transcript) region of the 
EBV virus genome on the complementary strand of the gene encoding the viral DNA 
polymerase protein BALF5 (Fig. 10). The mRNA of BALF5 has been shown to be the target 
of microRNA-BART2 and binding of miR-BART2 leads to cleavage of the transcript (144). 
The functional significance of this inhibition remains to be demonstrated. It is assumed, 
however, that the reduction of viral replication levels promotes latency and prevents EBV 
from switching to the lytic stage of its life cycle. This is also supported by the finding that 
microRNAs encoded in the EBV-BART cluster are expressed at very low levels in freshly 
infected B-cells, but at significantly higher levels in infected cells that undergo type II latency 
(131,145).  
Figure 10. Genomic position and predicted secondary structure of EBV miR-BART2. A) miR-
BART2 is encoded antisense to the BALF5 DNA Polymerase gene.  B) The mature microRNA 
BART2 (marked in red) corresponds to the 5’-arm of the precursor-microRNA hairpin (red). Modified 
from Pfeffer et al., Science, 2004. 
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2 AIMS 
 
The aim of this thesis is the characterization of endogenous as well as heterologous 
RNA sequence elements in the terminal regions of the tick-borne encephalitis virus. This 
overall goal can be subdivided into three individual projects that address different but 
interrelated questions: 
 
(I) Unraveling the role of the tick-borne encephalitis virus 3‘-noncoding region in 
viral translation and replication. 
The 3‘-NCR region of tick-borne encephalitis virus is composed of a variable and a 
core region. In some strains the variable region also contains an internal poly-A 
stretch. Although the core region has been subject to several studies that amongst 
others led to the identification of the genome cyclization sequences which are 
involved in viral RNA replication, less is known about the role of the variable region. 
Using a sensitive luciferase-based replicon system, mutations and alterations should 
be engineered in the variable region and tested for their effect on viral input RNA 
translation and/or RNA replication. This should also include the complete removal of 
the poly-A tract and the substitution of the variable region with heterologous protein 
binding elements. 
 
(II) Assessment of the capability of tick-borne encephalitis virus to encode 
functional microRNAs. 
Although it has been shown for several DNA viruses that they encode microRNAs for 
post-transcriptional regulation of host or viral gene expression, no RNA virus 
microRNAs have so far been identified. Viruses that replicate in the cytoplasm of a 
host cell and whose genome is composed of a single RNA molecule are believed to 
be incompatible with microRNA biogenesis. Reasons for this assumption are that 
microRNA biogenesis is initiated in the nucleus and characterized by an RNA 
38 | A i m s  
 
cleavage step for the liberation of the microRNA hairpin, which in turn is expected to 
result in an impairment of RNA replication. 
To experimentally address the question whether the lack of identified RNA virus 
microRNAs necessarily means that these viruses are unable to encode and to 
generate these regulatory molecules, a heterologous DNA virus microRNA-precursor 
should be selected and inserted into the genome of TBEV, followed by the 
characterization of this virus and a screen for generated microRNAs. In addition a 
dual luciferase reporter assay should be developed to simultaneously monitor viral 
RNA replication levels and microRNA activity in a replicon system. Thereby the 
results of this project should contribute to the conceptive understanding of microRNA 
biogenesis in the context of RNA virus genomes and reach far beyond the used 
model virus tick-borne-encephalitis virus.  
 
(III) Mutational analysis of the conserved RNA stem-loop sequence elements 5‘-
SL2, 5‘-SL3 and 5‘-SL4 in the tick-borne encephalitis 5‘-noncoding region. 
The 5‘-terminal region of flaviviruses contains conserved RNA stem-loop motifs that 
are crucial for RNA replication and translation. It has been shown for instance that the 
5‘-SL2 contains the 5‘-part of the genome cyclization sequence. As the essential 
switch of the genomic RNA from the linear to a circular form is feasible only, if the 
hairpin retains the possibility to break up, it is very likely that the thermodynamic 
stability of this structure is of substantial importance in this process.  
To clarify which of those hairpins are involved in viral RNA translation and/or 
replication and to analyze the importance of their thermodynamic stability, stabilizing, 
destabilizing and hairpin obviating mutations should be introduced and tested for their 
effect on RNA replication and translation in the luciferase replicon system developed 
in (I). 
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The 3′-noncoding region (3′-NCR) of the ﬂavivirus genome includes a variable region that tolerates the
insertion of heterologous genetic information. Natural isolates of tick-borne encephalitis virus (TBEV) have
particularly long variable regions, which, for some strains, include an internal poly(A) tract. We constructed
luciferase reporter replicons of TBEV to analyze the impact of variousmanipulations of the 3′-NCRon viral RNA
translation and replication. The choice of the reporter gene, its position and processing within the viral
polyprotein, and the choice of standards were found to be important for obtaining a sensitive and reliable test
system. We observed that truncation or complete removal of the internal poly(A) tract, or even the entire
variable region, had no signiﬁcant impact on translation and replication of the RNA inmammalian cell culture.
Substitution of the variable regionwith foreign genetic elements impaired RNA replication to various degrees
but generally had no inﬂuence on viral translation. Expression cassettes driven by an IRES element inhibited
RNA replication more strongly than did repetitive protein-binding elements derived from a bacteriophage,
evenwhen the ligand that binds these elements was co-expressed in the cells. Previously identiﬁedmutations
in the IRES partially relieved this inhibition when introduced into the reporter replicon but provided no
evidence for intramolecular competition for translation factors. Impairment of replication appeared to depend
more on the type of foreign insert than on its length. These results provide a rational basis for the construction
of TBEV-based vectors or vaccines as well as molecular tools for studying ﬂavivirus replication.
© 2008 Elsevier Inc. All rights reserved.
Introduction
Flaviviruses (members of the genus Flavivirus, family Flaviviridae)
are small enveloped viruses with a positive-stranded RNA genome
(Lindenbach et al., 2007). Most ﬂaviviruses are transmitted by
arthropods to vertebrates and replicate in both hosts. The genus can
be further divided into two major groups based on the arthropod
vector in which the virus can replicate: the mosquito-borne ﬂavi-
viruses, which include the dengue viruses, yellow fever virus, West
Nile virus, and Japanese encephalitis virus, and the tick-borne
ﬂaviviruses, of which tick-borne encephalitis virus (TBEV) is the most
important human-pathogen (Gubler et al., 2007). Although the overall
genome structure, replication strategy, and individual protein func-
tions are conserved between the mosquito- and tick-borne ﬂavi-
viruses, there are nevertheless important differences that determine
their vector speciﬁcity and pathogenic potential.
All ﬂaviviruses have a genome consisting of a single positive-sense
RNA molecule that is approximately 11 kb long, has a 5′ methylgua-
nylate cap, and lacks a poly(A) tail (Lindenbach et al., 2007; Wengler,
1981; Wengler and Gross, 1978). This genomic RNA is infectious when
introduced into cells by transfection and can beused immediately as an
mRNA for translation of a single open reading frame that encodes a
polyprotein precursor of the three structural (C, prM, and E) and seven
nonstructural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins.
The individual viral proteins are made from the precursor by co- and
posttranslational processing by the viral NS2B/3 protease and host-cell
proteases (Lindenbach et al., 2007). The genomic RNA is also used as a
template forminus-strand RNA synthesis and genome replication (Chu
and Westaway, 1985). It can also be packaged into infectious virions
after sufﬁcient amounts of the necessary structural components have
been synthesized. Genomes from which some or all of the structural
genes have been deleted are still able to replicate in the cell, and these
artiﬁcial replicons have a number of potentially useful applications,
both as tools for basic research and for development of gene-delivery
systems and vaccines (Gehrke et al., 2005; Khromykh, 2000; Shi et al.,
2002; Yoshii et al., 2005). One way in which mosquito- and tick-borne
ﬂaviviruses differ is in the sequences and positions of speciﬁc func-
tional RNAelements located near the 5′ and 3′ ends of the RNA genome
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(Koﬂer et al., 2006; Mandl et al., 1993). These regions are involved in
RNA replication, translation, and possibly also genome packaging
(Markoff, 2003). Although the speciﬁc functions of some elements
have been identiﬁed, it is often difﬁcult to distinguish between these
functions because they are interdependent, and most assay systems
measuring the effects of speciﬁc mutations on virus growth, viral
protein expression, or synthesis of viral RNA are actually measuring a
combination of effects.
Using various artiﬁcial experimental systems including replicons and
reporter constructs, it has already been possible to deﬁne the roles of
particular conserved RNA elements in the 5′- and 3′-terminal regions of
mosquito-borne ﬂaviviruses (Alvarez et al., 2005; Chiu et al., 2005; Deas
et al., 2005; Edgil et al., 2003; Filomatori et al., 2006; Holden and Harris,
2004;Holden et al., 2006; Lo et al., 2003; Tilgner et al., 2005; Tilgner and
Shi, 2004). However, some of the analogous elements in tick-borne
ﬂaviviruses have different sequences and secondary structures from
those of themosquito-borne viruses, and sometimes they are located at
a different position in the genome (Mandl et al., 1993; Markoff, 2003).
For example, it was shown recently that the RNA cyclization elements
that are used in theTBEV replicationmechanismare not only different in
sequence from those in mosquito-borne ﬂaviviruses, but they are also
closer to the ends of the RNA molecule and do not overlap with the
coding region (Koﬂer et al., 2006). Additional experimental systems are
therefore needed to functionally map the noncoding regions of tick-
borne ﬂaviviruses and to compare them to those of themosquito-borne
ﬂaviviruses.
The 3′-NCR (3′-noncoding region) of TBEV is extremely variable in
length, ranging from about 450 to 800 nucleotides (nts) in natural
isolates (Wallner et al., 1995). It is further subdivided into a highly
conserved “core” region of about 340 nucleotides at the extreme 3′ end
and a “variable” region between the core and the end of the coding
region. The core consists primarily of conserved RNA secondary struc-
tures that are essential for viral replication (Hahn et al., 1987; Mandl
et al., 1993, 1998; Pletnev, 2001; Rauscher et al., 1997; Wallner et al.,
1995). The variable region lacks sequence conservation and can be of
different lengths. In some, but not all, TBEV isolates, it contains an
internal poly(A) tract that can range in size from just a few to 200 or
more consecutive adenine residues (Mandl et al., 1998, 1991). While it
has been shown that the components of the variable region are
not essential for virus growth, it still remains to be established wheth-
er they might have an effect on the efﬁciency of RNA replication or
translation under some conditions.
TBEV and replicons derived from it have been shown in earlier
studies to have potential as a basis for constructing replicating RNA
vectors for use in basic research as well as vaccine development, and
these vectors have advantages over DNA-based systems in terms of
efﬁciency and safety (Khromykh, 2000; Khromykh and Westaway,
1997). Bicistronic expression systems have been successfully con-
structed by replacing the variable region with expression cassettes
containing an internal ribosome entry site (IRES), but, for reasons that
are not yet completely clear, these replicate inefﬁciently compared to
the parental replicon (Jones et al., 2005; Khromykh and Westaway,
1997; Orlinger et al., 2006; Scholle et al., 2004; Shi et al., 2002).
In this study, we have established a luciferase reporter replicon
system for TBEV that allows effects of alterations in the genome on
translation and RNA replication to be analyzed separately. Using
appropriate standards for normalization, we have now been able to
do quantitative comparisons between different constructs and thus
assess the effects of different changes in the 3′-NCR. We have used
this system to do a systematic deletion analysis of the variable region
and found that this region does not signiﬁcantly affect translation or
RNA replication efﬁciency. We have also tested the effects of in-
serting different expression cassettes and RNA elements that bind
speciﬁc proteins and found that these also do not affect translation,
although they have a negative effect on RNA replication. The results
of this study underscore the great practical potential for using the
variable region of the TBEV 3′-NCR as a site for insertion of various
genes and RNA elements for the purpose of establishing replicating
systems for foreign gene delivery, studies of RNA movement and
turnover, and vaccine development.
Results
Construction and characterization of reporter replicons
To establish a sensitive reporter system for measuring the level of
cap-dependent translation of TBEV replicon RNA, we made plasmid
constructs for use as templates for in vitro synthesis of capped RNA in
which most of the region of the TBEV genome encoding the structural
proteins C, prM, and E was replaced in-frame by a luciferase reporter
gene. In these constructs, the natural translation initiation site of the
viral polyproteinwas retained together with the ﬁrst 17, 27, or 37 amino
acids of the capsid protein fused to the reporter (Fig.1). The rest of the C
gene, the entire prM gene, and all of the E gene except for the second
transmembrane region (TM2) were deleted. The TM2 portion of E was
retained because it also serves as an internal signal sequence for
establishing the proper topology of the polyprotein in the ERmembrane
and targeting of the nonstructural protein NS1 to the secretory pathway
(Lindenbach et al., 2007). The sequence was preceded by a recognition
sequence (Arg-Arg-Ser) for the replicon-encoded viral NS2B/3 protease
Fig. 1. Schematic diagram of TBEV reporter replicons. A generalized scheme showing
the common features of all of the replicons (not to scale) is shown at the top of the
ﬁgure, and the speciﬁc features of the individual constructs are illustrated below it.
5′-NCR, 5′-noncoding region; 3′-NCR, 3′-noncoding region; Ctruc, truncated capsid
gene; luc, luciferase gene; E472, codon 472 of the E protein gene; NS1–NS5, the
coding region for nonstructural proteins 1–5; C17, C27, and C37, truncated C genes
containing only the ﬁrst 17, 27, and 37 codons, respectively; Rluc, the Renilla
luciferase gene; ﬂuc, the ﬁreﬂy luciferase gene; NS2B/3, cleavage site for TBEV NS2B/
3 protease; FMDV2A, foot-and-mouth disease virus 2A site; TaV2A, Thosea asigna
virus 2A site; GAA, site of GDD-GAA mutation in the NS5 polymerase active site.
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to allow the luciferase to be liberated posttranslationally from the
polyproteinprecursor. In some constructs, a 2A sequence from foot-and-
mouth disease virus or fromThosea asignaviruswas inserted in order to
compare the efﬁciency of these different systems. In these experiments,
two different luciferase genes were tested as reporter genes: Renilla
luciferase (Rluc) and ﬁreﬂy luciferase (ﬂuc).
When BHK-21 cells were transfected by electroporationwith capped
replicon RNAmade by in vitro transcription of a construct containing the
ﬁrst 17 codons of the C region fused to ﬁreﬂy luciferase (C17ﬂuc, Fig. 1),
there was a biphasic pattern of luciferase activity over a time course of
72 h (Fig. 2A). The ﬁrst peak, which appeared within the ﬁrst 2 h after
transfection, shows that the initial input RNAwas translated in the cell,
yielding a functional luciferase enzyme. After a subsequent decrease in
luciferase activity indicative of a decrease in translation (probably due to
degradation of the input RNA), a second, higher peak of luciferase ac-
tivity was detected which began to increase around 12 h after trans-
fection. This second peak represents luciferase that was expressed from
newly synthesized sense-strand RNA after replication of the input RNA.
Similar biphasic proﬁles have been observed previously with reporter
replicon systems derived from mosquito-borne ﬂaviviruses (Alvarez
et al., 2005; Filomatori et al., 2006; Holden et al., 2006; Lo et al., 2003).
Surprisingly, in contrast to the C17ﬂuc construct, an analogous
construct that instead contained the luciferase gene from Renilla,
C17Rluc (Fig. 1), did not yield a biphasic proﬁle, giving rise to only the
ﬁrst peak, corresponding to translation of the input RNA (Fig. 2B). This
observation indicates that although the C17Rluc RNA is competent for
cap-dependent translation and expression of functional Renilla lucifer-
ase, this RNA, unexpectedly, is not able to replicate efﬁciently in BHK-21
cells. This lack of efﬁcient replication was also reﬂected by a lack of
detectable NS1 protein in immunoﬂuorescence assays carried out three
days after transfection (Fig. 2C).
We speculated that the C17Rluc fusion might have resulted in a
fortuitous disruption of the local RNA secondary structure that inter-
feredwithRNA replication.We thereforemade additional constructs in
which the Rluc gene was inserted at a position farther downstream,
reasoning that increasing the distance between the luciferase gene and
the putative RNA secondary structure element in the 5′ portion of the
genome might alleviate this problem. The ﬁrst of these, C27Rluc, con-
tained the ﬁrst 27 amino acids of C fused to the reporter gene, and the
second, C37Rluc, contained 37 amino acids (Fig. 1). Interestingly, RNA
replication competence was indeed observed when capped RNA de-
rived from each of these constructs was used to transfect BHK-21 cells,
with both constructs yielding a biphasic proﬁle similar to the one
obtained with C17ﬂuc (Fig. 2B). Both of these also yielded positive
results in the immunoﬂuorescence assay with anti-NS1 antibody, in
contrast to C17Rluc (Fig. 2C). This demonstrates that although insertion
of the Rluc gene is tolerated in some contexts, the C17Rluc fusion
apparently interferes with replication of the replicon RNA.
For reasons of consistency and comparability of data, we chose to
use C17ﬂuc constructs in all of the experiments discussed below,
because the C17 replicon used for constructing C17ﬂuc had been ex-
tensively characterized in an earlier study (Koﬂer et al., 2006).
Because the constructs described above rely on the viral NS2B/3
protease encoded in the replicon itself for release of the luciferase
reporter enzyme from the polyprotein precursor, we decided to test
whether the efﬁciencyof reporter expression (and thus the sensitivity of
the system) could be improved by introducing alternative processing
sites after the reporter gene that would free the replicon from the
constraint of having to provide its own processing enzyme. This ap-
proach has been used successfully in earlier studieswith other ﬂavivirus
reporter replicons (Alvarez et al., 2005). For this purpose, two different
siteswere engineered into the region of C17ﬂucbetween the C-terminus
of the ﬂuc gene and the NS1 signal peptide (see Materials and methods
for details). The ﬁrst of these was the 2A site from foot-and-mouth
disease virus (FMDV2A), which introduces a gap in the polyprotein
during translation by a “topGo” mechanism rather than a proteolytic
cleavage event (Atkins et al., 2007; de Felipe et al., 2003; Donnelly et al.,
2001b). The secondwas the analogous 2A site from Thosea asigna virus
(TaV2A) (Donnelly et al., 2001a).
As shown in Fig. 3A, when the relative amounts of ﬂuc activity were
compared 3 h after transfection of BHK-21 cells with capped RNA made
fromtheseconstructs, theFMDV2AandtheTaV2A repliconsbothyielded
considerably higher levels of luminescence than did the original C17ﬂuc
construct containing the TBEV NS2B/3 cleavage site. The luminescence
intensity was more than two-fold higher with the FMDV2A construct
and about three-fold higher with the TaV2A construct. Furthermore,
Fig. 2. (A) Kinetics of ﬁreﬂy luciferase activity in BHK-21 cells transfectedwith C17ﬂuc. Mock, mock-transfected cells; RLUs, relative light units. (B) Kinetics of Renilla luciferase activity
in BHK-21 cells transfected with C17Rluc, C27Rluc, or C37Rluc. (C) NS1 expression measured by immunoﬂuorescence with an NS1-speciﬁc monoclonal antibody three days after
transfection with replicon C17Rluc, C27Rluc, or C37Rluc, or a replication-deﬁcient mutant, ΔNS5 (Koﬂer et al., 2006), which was used as a control.
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signiﬁcant differences in luminescence intensity were observed at later
time points, after RNA replication had taken place. As shown in Fig. 3A,
the luminescenceyield44h after transfectionwasabout20 times higher
with the FMDV2A construct and more than 25 times higher with the
TaV2A construct thanwith the original construct containing the NS2B/3
cleavage site. This result was conﬁrmed by immunoblotting 48 h after
transfection with antibodies speciﬁc for ﬂuc or the TBEV NS1 protein
(Fig. 3B). Signiﬁcantly more ﬂuc was present in the cells at this time
point when the gene was followed by the TaV2A or the FMDV2A site
instead of the NS2B/3 site suggesting a more efﬁcient release of ﬂuc. It
seems reasonable to conclude that the faster processing of the ﬂuc-NS1
junction region greatly increases the sensitivity of this reporter system.
We therefore chose the more efﬁcient of these two, C17ﬂuc-TaV2A, for
use in further experiments investigating the effect of changes in the
TBEV 3′-NCR on translation and RNA replication.
Standardization for quantitative comparisons
Luciferase reporter systems are very sensitive tools that can be used
to make quantitative comparisons of translation and replication levels
with different constructs, but for such comparisons, proper standardiza-
tion is needed to normalize factors such as transfection efﬁciency. This is
typically accomplished by using two different luciferase enzymes that
use different substrates — one as the main reporter and the other,
provided by cotransfection with a control construct, to provide a quan-
titative measure of transfection efﬁciency (Schagat et al., 2007). In the
experiments described below, ﬁreﬂy luciferase was used as the reporter
in the C17ﬂuc-TaV2A replicon, and this was used together with either
RNA or DNA containing the Renilla luciferase gene as a transfection
control for normalization. For experiments examining early time points
corresponding to the translation of input RNA (up to 12 h posttransfec-
tion), capped mRNA transcribed in vitro from the Rluc expression
plasmid phRL-SV40 (Promega) was used as the transfection control,
whereas formeasuring translation of replicated RNAat later timepoints,
after most of the input RNA had already been degraded, the expression
plasmid itself (DNA instead of RNA) was used as the control. In our
hands, Rluc expression in cells transfectedwith plasmid phRL-SV40was
detectable at 6 h after transfection and for the entire time thereafter that
expression was monitored (70–96 h) (data not shown).
In order to conﬁrm the correlation of the ﬁrst and the second peak
to translation and replication, respectively, ﬂuc activity was mon-
itored in BHK-21 cells transfected with C17ﬂuc-TaV2A replicon RNA
and compared to a replication-deﬁcient variant of this replicon, NS5-
GAA, and an in vitro-transcribed but uncapped C17ﬂuc-TaV2A control
RNA. NS5-GAA was identical to C17ﬂuc-TaV2A except that it con-
tained a mutated active-site motif (GDD-to-GAA) in the polymerase
domain of NS5. This experiment demonstrated that the GDD-to-GAA
mutation, which abolishes viral RNA replication, but not the ability
of the RNA to be translated, yielded a proﬁle in which the ﬁrst
(translation) peak was unchanged but the second (replication) peak
was absent. Conversely, the uncapped replicon control, which ini-
tially was translated inefﬁciently due to the lack of a 5′-cap, produced
only the later peak after new capped copies of this RNA had been
produced in the cells (Chiu et al., 2005). This result could be re-
produced in an experiment in which different time points were
analyzed (not shown). The reporter replicon system therefore allows
alterations affecting viral RNA replication to be distinguished from
those affecting translation.
The correlation between luciferase activity and RNA replication
was conﬁrmed in a separate kinetics experiment in which the ﬂuc
activity of cells transfected with capped C17ﬂuc-TaV2A and NS5-GAA
RNA closely paralleled the number of copies of the RNA genome
measured at different time points by quantitative PCR (Fig. 4B).
Effect of deletions in the variable region of the 3′-NCR
We next used the C17ﬂuc-TaV2A reporter replicon to examine
whether the variable region of the 3′-NCR plays a role in the efﬁciency
of cap-dependent translation or replication of the viral genomic RNA.
Some natural isolates of TBEV contain large internal poly(A) tracts in
this region, whereas others may contain either short poly(A) stretches
or none at all (Mandl et al., 1991; Wallner et al., 1995). Although some
studies have shown that the poly(A) element can be deleted and is
therefore not essential (Mandl et al., 1998), it has not been clear
whether it might nevertheless provide a subtle advantage in either
RNA replication or translation efﬁciency.
To test this question, wemade three additional constructs inwhich
different amounts of the variable region were removed from the
reporter replicon, which initially contained a stretch of 49 adenines
derived from the original infectious clone of TBEV prototype strain
Neudoerﬂ (Mandl et al., 1997). In the ﬁrst of these (replicon 9A), all but
9 adenines were removed, in the second (replicon ΔpolyA), all of the
poly(A) tract was removed, and in the third (replicon Δvar), the entire
variable region (nucleotides 10378 to 10795) was deleted (Fig. 5A).
These constructs were used to make capped RNA transcripts in vitro,
which were then used together with the appropriate Rluc control
RNA or plasmid for transfection of BHK-21 cells. For comparison
of translation efﬁciency of the different constructs, ﬂuc activity was
measured 3 h after transfection and normalized using the Rluc RNA
Fig. 3. Effect of different processing sites at the C-terminus of the ﬁreﬂy luciferase gene.
(A) Relative luciferase activity at different time points in BHK-21 cells transfected with
C17ﬂuc-TaV2A or C17ﬂuc-FMDV2A expressed as a ratio to that of C17ﬂuc (using the
NS2B/3 protease site) at the corresponding time point. Error bars represent the standard
deviation from a minimum of two independent experiments. (B) Relative processing
efﬁciency of C17ﬂuc, C17ﬂuc-FMDV2A, and C17ﬂuc-TaV2A. Cells harvested 48 h after
transfection were analyzed by immunoblotting using speciﬁc antibodies against ﬁreﬂy
luciferase (Anti-luc) or the TBEV NS1 protein (Anti-NS1). “Mock” is a mock-transfected
control, and “ΔR88” is a prM-cleavage-deﬁcient TBEV mutant (Elshuber and Mandl,
2005) used as a positive control for NS1 expression and processing.
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standard. RNA from the replication-defective NS5-GAA construct
described in the previous section was included as a control.
As shown in Fig. 5B, the level of expression of luciferase from the
input RNA was essentially identical for all of the constructs, indicating
that the presence or absence of the poly(A) tract does not signiﬁcantly
affect the efﬁciency of cap-dependent translation from the viral poly-
protein start site. Although the somewhat lower luciferase values
obtainedwithΔvar do suggest that deletion of the entire variable region
might have caused a slight reduction, this difference was within the
error range of our test system.When luciferase levels were examined at
later time points (13–68 h after transfection), it was again observed that
none of these deletions had any observable effect on ﬂuc expression
(Fig. 5C), indicating that neither translation nor RNA replication ef-
ﬁciency is affected by removing part or all of the variable region.
Effect of replacing the variable region with expression cassettes
In earlier studies investigating the use of TBEV replicons for making
bicistronic expression systems, it was observed that insertion of ex-
pression cassettes containing an internal ribosome entry site from
encephalomyocarditis virus (EMCV IRES) into the variable region of the
3′-NCR resulted in reduced levels of RNA replication and expression
of viral genes from the natural cap-dependent translation start site
Fig. 4. Normalization and biphasic kinetics of ﬁreﬂy luciferase activity in BHK-21 cells
transfectedwith C17ﬂuc-TaV2A. (A) BHK-21 cellswere transfectedwith capped (+cap) or
uncapped (−cap) C17ﬂuc-TaV2A RNA or capped NS5-GAA RNA. Luciferase values were
normalized to an internal RNA control. (B) Comparison of luciferase activity (dashed
lineswith triangles) with RNA copy number asmeasured by quantitative PCR (solid lines
with circles) at different time points. For the luciferase data, logarithmicmeans from two
separate experiments are shown. Error bars represent the standard deviation from two
independent experiments.
Fig. 5. Lack of effect of deletions in the variable region of the 3′-NCR on translation and
replication. (A) Schematic diagram showing the positions of the deletions. The original
construct contained 49 adenine residues, of which all but nine were deleted in replicon
9A. All 49 adenines (nucleotides 10489–10537) were deleted in replicon ΔpolyA, and
the entire variable region (nucleotides 10378–10795) was deleted in replicon Δvar.
(B) Comparison of levels of translation of input RNA from the different constructs using
normalized luciferase data obtained 3 h posttransfection. The error bars show the
standard deviation from at least three different experiments, and the scale of the y-axis
is linear. (C) Normalized luciferase activity (log scale) at later time points (10–70 h
posttransfection), corresponding to the kinetics of RNA replication. Capped NS5-GAA
RNA, which can be translated (see panel B) but cannot replicate because its RNA
polymerase is nonfunctional, was used as a control.
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(Orlinger et al., 2006) and that certain point mutations and small
insertions in the IRES element that decreased the translation efﬁciency
of the IRES itself mitigated these effects (Gehrke et al., 2005; Orlinger
et al., 2007). In these studies itwas speculated thatbindingof a ribosome
to the IRES in the 3′-NCR might interfere with translation of the cap-
dependent cistronbya different ribosome, block the synthesis ofminus-
strand RNAby the viral polymerase, or possibly both. Here,wewere able
to address this question using the newly established reporter replicon
system.
The following expression cassettes from earlier studies were used
for these experiments: 1) IRES-eGFP (Gehrke et al., 2005), which
encodes an enhanced green ﬂuorescent protein (eGFP) under the
control of an EMCV IRES, 2) IRES-ME (Orlinger et al., 2006), which
contains the region encoding the TBEV prM and E proteins under the
control of an EMCV IRES, and 3) IRES(A771C)ME and 4) IRES(26A)ME
(Orlinger et al., 2007),which are variants of IRES-ME thatwere selected
during propagation of a self-replicating artiﬁcial bicistronic TBEV
genome, TBE-bc. The ﬁrst of these contains an A–C substitution at
nucleotide position 771 in the oligo(A) loop of the JK stem–loop
structure of the IRES element, and the second contains an insertion of
19 additional adenines in this same oligo(A) loop, thus increasing the
total number in the original loop from 7 to 26. In the context of the
artiﬁcial bicistronic TBEV, both of these were shown to provide a
growth advantage over the parental construct while weakening the
translation capacity of the IRES itself (Orlinger et al., 2007).
Each of the expression cassettes described above was cloned into
the C17ﬂuc-TaV2A reporter replicon (Fig. 6A) as described in Materials
and methods, and the resulting cDNAs were used as templates for
in vitro synthesis of capped RNA. Equimolar amounts of each RNA
were used for transfection of BHK-21 cells, together with the ap-
propriate Rluc standard for normalization, as discussed above, and ﬂuc
and Rluc activity were measured at different time points after trans-
fection. As controls, the parental reporter replicon and the replication-
defective mutant NS5-GAA were also used.
As shown in Figs 6B and C the normalized ﬂuc activity at 3 h
posttransfection was similar for all of the constructs examined, in-
dicating that, similar to what was observed with the deletions in the
variable region, the expression cassettes tested here clearly did not
have a strong effect on the efﬁciency of cap-dependent translation.
Furthermore, the IRES mutations that had been selected previously
(A771C and26A) didnot demonstrate signiﬁcantly increased efﬁciency
of translation of the input RNA (Fig. 6C). Thismeans that the hypothesis
that mutations causing weaker binding of the ribosome to the IRES
had increased the ﬁtness of the original bicistronic RNA by reducing
competition for ribosomes between the IRES and cap cistrons is not
supported.
In contrast to the 3-hour time point, signiﬁcant differences were
found at later time points, suggesting differences in the rate of accu-
mulation of RNA in the cell. As shown in Fig. 6B, the reporter replicons
containing the IRES-eGFP cassette and the IRES-ME cassette both
displayed reduced luciferase expression compared to the parental
replicon: with the IRES-eGFP construct it was 10–50-fold (1–1.7 log)
lower, and with IRES-ME it was 10–440-fold (1-2.6 log) lower. Fur-
thermore, in both of these cases, replication proceeded with a delay
when compared to the replicon without an insertion. Interestingly,
reporter replicons containing the IRES-ME cassette with the IRES
mutations A771C or 26A had about 10 times higher luciferase levels
than the IRES-ME construct with a normal IRES, suggesting that these
Fig. 6. Effect of IRES-containing expression cassettes in the 3′-NCRon cap-dependent translation and RNA replication. (A) Schematic diagramof the C17ﬂuc-TaV2Aderivatives IRES-ME
and IRES-eGFP. The position of the EMCV IRES in each construct is indicated, and its secondary structure is depicted. The position of the A771C and 26A mutations within the IRES is
indicated by an asterisk. IRES-ME, IRES(A771C)ME and IRES(26A)ME contain the region encoding the TBEV prM and E proteins, and IRES-eGFP contains the gene for the enhanced green
ﬂuorescent protein (eGFP). (B) Kinetics of reporter expression in BHK-21 cells transfected with IRES-ME, mutant IRES(A771C)ME, or mutant IRES(26A)ME, shown on a logarithmic scale.
(C) Kinetics of reporter expression in BHK-21 cells transfected with IRES-ME, IRES-eGFP, C17ﬂuc-TaV2A, or replication-deﬁcient NS5-GAA, shown on a logarithmic scale. Error bars
represent the standard deviation from a minimum of three independent experiments.
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mutations had a positive effect on RNA replication efﬁciency (Fig. 6C).
These results together imply that the presence of an expression cassette
in the 3′-NCR, and probably the IRES itself, interferes with RNA
replication, but it does not inﬂuence translation fromthe cap-dependent
start site at the 5′ end.
Effect of replacing the variable region with protein-binding elements
In addition to its previously demonstrated usefulness as a site for
inserting genes for foreign protein expression, the variable region of
the TBEV 3′-NCR also has the potential to be used as a site for inserting
a speciﬁc RNA–protein interaction sequence for GFP-tagged cognate
ligands. In fact, it has been reported that insertion of recognition
elements from the bacteriophage MS2 coat protein allows RNA
molecules to be detected in cells expressing an MS2 coat protein
fused to the green ﬂuorescent protein (GFP) (Bertrand et al., 1998).
This method allowed for the ﬁrst time the study of mRNA biogenesis
in real time in live cells (Boireau et al., 2007; Darzacq et al., 2007). We
therefore made constructs in which the variable region of the TBEV
reporter repliconwas replaced by 12 or 24 copies of the 19-nucleotide
MS2 repeat element to study the effect of these elements, both in the
presence and absence of the EYFP-MS2 (enhanced yellow ﬂuorescence
protein) fusion protein, on translation and replication of the replicon
RNA using the luciferase reporter assay (Fig. 7A). As in the previous
experiments, capped RNA was made in vitro and used together with
the transfection standard for electroporation of BHK-21 cells, but in
addition, some of the cells were also simultaneously transfected with
plasmid pEYFP-MS2, which contains the gene for the bacteriophage
MS2 core protein fused to EYFP driven by the CMV promoter (see
accompanying paper by Miorin et al., submitted). As shown in Fig. 7B,
neither the 12- nor the 24-repeat insertion had a signiﬁcant effect on
translation of the input RNA, and normalized luciferase levels 3 h after
transfectionwere similar for these constructs and the controls. At later
time points, however, luciferase levels remained somewhat lower
(about ten-fold) in cells transfected with RNAs containing the repeats
than in cells transfected with the parental C17ﬂuc-TaV2A construct
(Fig. 7B), suggesting a modest effect of these elements on RNA
replication. This effect does not appear to be proportional to the size of
the inserted sequence, since 12xMS2 and 24xMS2 yielded essentially
identical curves.
In cells in which 12xMS2, 24xMS2, or the parental construct were
cotransfected with the plasmid encoding the EYFP-MS2 protein, no
additional effect was observed at any of the time points (Fig. 7C). There
is therefore no indication from this set of experiments that EYFP-MS2,
when expressed in this manner, interferes at all with translation or
replication of the replicon RNA, regardless of whether or not there are
copies of its target sequences present in the 3′-NCR of the replicon.
Together, these results support the potential use of TBE virus or
replicon RNA containing MS2 repeats to study viral RNA in living cells
using the EYFP-MS2 reporter.
Discussion
In this study, a functional analysis of the variable region of the
TBEV 3′-NCR was performed using a simple and sensitive system to
measure both replication and primary translation of self-replicating
RNA. The variable region of most strains of TBEV is signiﬁcantly longer
than in mosquito-borne ﬂavivirus genomes (Bryant et al., 2005;
Gritsun et al., 1997; Ma et al., 2003; Mandl et al., 1998, 1991; Markoff,
2003; Yang et al., 2004). Some strains, such as the prototypic strain
Neudoerﬂ, carry an internal poly(A) region of variable length which
may further elongate during viral growth (unpublished observation).
Fig. 7. Effect of insertion of MS2 coat protein-binding sites into the 3′-NCR on cap-dependent translation and RNA replication. (A) Schematic diagram of C17ﬂuc-TaV2A derivatives
12xMS2 and 24xMS2, which contain 12 and 24 copies, respectively, of the MS2 recognition site. (B) Kinetics of reporter expression in BHK-21 cells transfected with 12xMS2, 24xMS2,
C17ﬂuc-TaV2A, or replication-deﬁcient NS5-GAA, shown on a logarithmic scale. Error bars represent the standard deviation from a minimum of three independent experiments.
(C) Lack of interference of enhanced yellow ﬂuorescent protein-tagged MS2 coat protein (EYFP-MS2) with luciferase expression from reporter constructs containing binding sites for
this protein. BHK-21 cells were either transfected with C17ﬂuc-TaV2A, 12xMS2, or 24xMS2 alone or cotransfected with a mixture of replicon RNA and plasmid pEYFP-MS2, as
indicated below the ﬁgure. The data, shown on a logarithmic scale, are normalized luciferase values measured 44 h after transfection. A similar lack of effect of coexpression with
pEYFP-MS2 was also observed at 13, 15, 18, 21, 23 and 68 h posttransfection (data not shown).
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On the other hand, repeated passages can also result in spontaneous
deletions of parts of the variable region, including the poly(A) tract
(Mandl et al., 1998). Strains with shorter variable regions, or that
entirely lack this region, were previously found tomaintain viability in
cell culture and virulence in mice (Mandl et al., 1998). Here, we
wanted to ﬁnd out whether the presence and length of the variable
region and its poly(A) tract had a measurable inﬂuence on the ef-
ﬁciency of translation and/or RNA replication of TBEV. We did not ﬁnd
any such inﬂuence in our experiments, indicating that these elements
are entirely dispensable in BHK-21 cells. This ﬁnding contrasts with
recent results obtained with dengue viruses 1 and 2 (Alvarez et al.,
2005; Tajima et al., 2007). Deletion of the variable region of these
mosquito-borne ﬂaviviruses was shown to impair viral growth in
mammalian cells such as BHK-21 cells. Our ﬁndings were unexpected
also with regard to the fact that the 3′-terminal poly(A) stretches of
cellular mRNAs are targeted by speciﬁc cellular factors (Grange et al.,
1987; Mangus et al., 2003; Sachs et al., 1997; Tarun and Sachs, 1996)
and inﬂuence translation efﬁciency (Jacobson and Favreau, 1983;
Sachs et al., 1997). Furthermore, hepatitis C virus, another member of
the family Flaviviridae possesses within the 3′-NCR a poly(U/UC) tract.
The length of which is decisive for achieving maximal RNA ampliﬁca-
tion (You and Rice, 2008). Apparently, no such role is played by the
internal poly(A) stretch of TBEV, at least when tested in BHK-21 cells.
We have also tried to investigate the properties of our replicons in
a tick cell line, but we were unable to establish an adequate RNA
transfection protocol for these cells.
The observed lack of function of the TBEV variable region is a very
welcome ﬁnding with respect to the potential of this viral genome to
accept foreign genetic information. We and others have previously
demonstrated that expression cassettes under the control of a heter-
ologous IRES element can be inserted in place of this element in
the context of infectious genomes or replicons (Gehrke et al., 2005;
Hayasaka et al., 2004; Orlinger et al., 2006, 2007; Yoshii et al., 2005).
Using constructs in which the TBEV surface proteins required the
foreign IRES for their translation, we were recently able to select
mutations in the IRES itself that enhanced the ﬁtness of such
bicistronic viruses (Orlinger et al., 2007). In that study, the normal
IRES sequence was found to interfere with viral replication, but it
remained unclear whether this was primarily due to an inhibition of
RNA replication or competition of the IRES with cap-dependent
translation. The results obtained with the luciferase reporter indicate
that cap-dependent translation is not affected by the insertion of the
IRES, but RNA replication is signiﬁcantly impaired. The results also
suggest that the disturbance of RNA replication is even stronger with
longer expression cassettes. The previously identiﬁed IRES mutations
lessen the impact of the IRES on RNA replication but, unexpectedly,
have no inﬂuence on cap translation. One may hypothesize that IRES-
mediated binding of the input RNA to the ribosome may prevent the
RNA from entering compartments in which RNA replication can take
place, but does not impair its cap-dependent translation.
The utility of replacing the variable region with foreign genetic
elements is not restricted to expression cassettes. We also inserted
repetitive sequence elements that serve as speciﬁc recognition se-
quences for a phageMS2 capsid protein. Again, these insertions did not
interfere with cap-dependent translation. Notably, they had signiﬁ-
cantly less of a negative impact on RNA replication than the IRES
expression cassettes. Moreover, in the case of these noncoding se-
quences, there was no relationship observed between the length of
the insert and disturbance of RNA replication. A sequence of 1484
nucleotides caused a moderate reduction in replication that was equal
to that of a 742-nucleotide-long sequence. Thus, the capacity of the
TBEV genome to accept foreign sequence elements in place of the
variable region appears to be high. This is in good agreement with the
fact that some TBEV strains have very long variable regions, which
in the light of our results may be regarded as neither necessary nor
harmful for translation and replication. Maybe this indicates an im-
portant functional difference between TBEV and the mosquito-borne
ﬂaviviruses, which generally have shorter variable regions. Co-
expression of an EYFP-MS2 protein did not cause a further reduction
of RNA replication, although FACS analysis demonstrated that at least
40% of the cells expressed this protein, and in a separate study, the
EYFP-MS2 fusion protein has been found to bind efﬁciently to the TBEV
replicons containing the speciﬁc repeat sequence insertions (Miorin
et al., submitted, and unpublished data). Apparently, binding of a
cytoplasmic, soluble protein such as MS2 is well tolerated, suggesting
that such systems can be used to localize and quantify RNA synthesis
in vivo.
In addition to the exploration of the role of the TBEV variable
region and its potential to be substituted by various foreign genetic
elements, this study yielded several methological insights which may
be of more general importance for the generation and optimization of
replicating RNA reporter systems:
(i) The choice of the reporter gene, ﬁreﬂy luciferase versus Renilla
luciferase, can cause a dramatic difference in the replicative
ability of the system. The different outcomes obtained with
constructs containing the two luciferases, which are usually
thought to be functionally equivalent, were striking and
unexpected. Whereas the ﬁreﬂy construct replicated well,
the Renilla construct essentially did not replicate. Great care
was taken to exclude that any unintended mutations else-
where in the genome were responsible for this. Remarkably,
primary translation was not affected at all by the introduction
of the Renilla gene. In silico RNA folding analysis yielded no
explanation for these observations. No signiﬁcant changes in
the formation of RNA secondary structure or the cyclization of
the genomewere predicted to be caused by the insertion of the
Renilla gene (C. Thurner, unpublished observation). When 30
nucleotides (10 codons) of the originally deleted capsid protein
sequence were re-inserted into the construct (the C27-Rluc
construct), RNA replication was restored, suggesting that not
the insertion of the Renilla gene per se, but its proximity to the
5′-terminus was causing the problem. Possibly, an RNA
structure present in the Renilla coding sequence interferes
with the RNA replicationmechanism, but not translation, if it is
in spatial proximity to the 5′-NCR. This unexplained inhibitory
effect observed with this gene may be relevant for other
systems as well and should be considered by researchers
working with similar self-replicating RNA constructs.
(ii) The sensitivity of the system depends strongly on the choice of
the cleavage mechanism by which the reporter protein is
separated from the polyprotein. The direct comparison between
the cleavage site for the viral protease NS2B/3 and the FMDV2A
and TaV2A sites indicated that the highest reporter gene
expression was achieved with the TaV2A site. The TaV2A
sequence turned out to be somewhat more efﬁcient than the
FMDV2A sequence, which is widely used in various expression
systems. These two sites very rapidly introduce a break in the
growing polypeptide chain by a “StopGo” mechanism, as
demonstrated recently for the FMDV2A sequence (Atkins et al.,
2007). In contrast, cleavage of the NS2B/3 site depends on prior
translation and accumulation of the protease. Furthermore, in
some cases the site may not be efﬁciently recognized by the
protease, resulting, as demonstrated in our experiments, not only
in release of low levels of the reporter gene, but also in reduced
formation of protein NS1, which may in turn impair the for-
mation of replication complexes. While different cleavage mech-
anisms may perform best in different expression systems, our
observations illustrate the necessity to evaluate this process in
order to achieve optimal sensitivity of the system.
(iii) Standardization of ﬁreﬂy luciferase assays to study ﬂavivirus
translation and replication is critical to obtain a comparable set
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of data. However, the reporter gene expression needs to be
monitored for 96 h. Therefore, it is not possible to rely only on
the use of in vitro-transcribed Renilla luciferase RNA because it
becomes undetectable after a few hours, whereas expression
from a plasmid construct becomes detectable only at later
times. The use of both RNA and DNA as internal standards
resolves this issue and provides a convenient method to study
early time points after transfection, using Renilla luciferase
RNA, as well as late time points, using an expression plasmid.
In conclusion, the TBEV reporter replicon has proven to be a valuable
tool for the investigation of speciﬁc sequence elements that govern RNA
translation and replication. Future studies will target the stem–loop
structures and the embedded circularization elements close to the
genomic termini. Analysis of viral mutants has revealed that a variety of
speciﬁc genomic determinants that attenuate the virulence of TBEV, and
self-replicating, but non-infectious TBEV RNAs that produce subviral
particles have been developed (Koﬂer et al., 2004). Both of these
approaches may be useful for the development of new and safe live,
replicating ﬂavivirus vaccines. Finally, TBEV shows good potential as a
backbone for thegenerationof infectious or non-infectious genevectors.
For all of these approaches it is very important to better deﬁne, under-
stand and distinguish from each other molecular elements and speciﬁc
mutations that inﬂuence translation and/or RNA replication. Ultimately,
a better deﬁnition of such determinants will lead to the ability to
optimize and ﬁne-tune new vaccines and vectors with respect to their
replication and protein expression capacities.
Materials and methods
Reporter replicon construction
All of the replicon constructs described in this study are derivatives
of pTNd/c, an infectious cDNA clone of TBEV strainNeudoerﬂ (GenBank
accession number U27495), the prototype of the Western subtype
(Mandl et al.,1997), andwere constructedbymakingmodiﬁcations to a
previously described replicon construct, C17 (Koﬂer et al., 2006). This
construct contains the ﬁrst 17 codons of the N-terminal region of the
capsid protein, corresponding to nucleotides 133–183 (numbering
according to the full-length sequence of strain Neudoerﬂ), followed by
a large deletion extending from the beginning of the prMgene through
most of the region coding for the E protein (nucleotides 184–2386). The
deleted region was replaced by a small artiﬁcial multiple cloning site
(MCS) followed by a short recognition sequence for the TBEV protease
NS2B/3. C17 and all of its derivatives contain a T7promoter upstreamof
the viral sequence to enable in vitro transcription of the replicon RNA.
The sequences of the oligonucleotide primers used in this study are
given in Supplementary Table 1, and the different replicon constructs
are depicted in Fig. 1.
The reporter replicon C17Rluc was made by ﬁrst amplifying the Re-
nilla luciferase (Rluc) gene (933 nts) fromplasmid phRL-SV40 (Promega)
by PCR using primers F-PacI_Rluc and R-NotI_Rluc, trimming the PCR
product with PacI and NotI, and inserting it into the MCS of C17.
Replicons C27Rluc andC37Rlucweremadeby replacing aportion of
C17Rluc, extending from a SalI site upstream of the T7 promoter to the
PacI site between the truncated capsid gene and the luciferase gene,
with an otherwise identical fragment containing a longer extension of
the C gene at its 3′ end. This was accomplished by amplifying a region
of a related replicon construct containing all of the capsid protein
except for the 16 carboxy-terminal codons (pTNd/ΔME) (Gehrke et al.,
2003) using the forwardprimer F-SalI togetherwith the reverse primer
R-C27_PacI (for C27Rluc) or R-C37_PacI (for C37Rluc) to generate the
appropriate PCR product, which was then trimmed with SalI and PacI
and inserted in place of the shorter SalI–PacI fragment of C17Rluc.
To generate C17ﬂuc, the region containing the Renilla luciferase
gene was removed from the C17Rluc plasmid by digestion with PacI
and NotI and then replaced by a ﬁreﬂy luciferase (ﬂuc) gene (1649 nts)
that had been ampliﬁed by PCR from plasmid pGL3 (Promega) using
the forward and reverse primers (F-PacI_ﬂuc and R-NotI_ﬂuc) con-
taining restriction sites for PacI and NotI, respectively.
To construct C17ﬂuc-FMDV2A, a 60-nt region encoding the 2A site of
foot-and-mouthdisease viruswasampliﬁedbyPCR fromplasmidMSCV-
GFP2AHOXB4 (Klump et al., 2001) using the primers F-NotI_FMDV and
R-NotI_FMDV. The PCR product was then trimmed with NotI and in-
serted into the NotI site of C17ﬂuc. C17ﬂuc-TaV2Awasmade in the same
way as C17ﬂuc-FMDV2A, using the retroviral vector dsRed-2A-CDX4
(friendly gift from H. Klump) and primers F-NotI_TaV and R-NotI_TaV to
amplify a 60-nt region containing the Thosea asigna virus 2A site
(Donnelly et al., 2001a), whichwas likewise inserted into the NotI site of
C17ﬂuc.
The replication-negative mutant of C17ﬂuc-TaV2A, NS5-GAA,
was generated by changing the conserved GDD motif (9652–9660)
in the polymerase active site of NS5 to GAA using a GeneTailor Site-
Directed Mutagenesis System (Invitrogen) with mutagenic forward
primer F-mutGDD and a wild-type reverse primer.
Deletions and insertions in the variable region of the 3′-NCR
To create variants that either completely lacked the poly(A) tract
in the 3′-NCR or contained only 9 of the original 49 adenines,
appropriate forward primers (F-Dra-2 and F-Dra-3, respectively)
were designed that contained the desired sequence preceded by a
DraI site. Each of these forward primers was used together with the
reverse primer R-AgeI for PCR ampliﬁcation of the corresponding
region of a plasmid clone, pTNd/3′ (Mandl et al., 1997), containing the
3′ portion of the TBEV strain Neudoerﬂ genome. The PCR products
were trimmed with DraI and AgeI and inserted in place of a DraI/AgeI
fragment in pTNd/3′ extending from nucleotides 10484 to 10796.
Primers F-XbaI and R-AatII were then used to amplify the region
containing the modiﬁed poly(A) tract (nucleotides 9163–11145), and
the PCR product was trimmed with XbaI and AatII and inserted in
place of the corresponding region of C17ﬂuc-TaV2A to create the
replicon constructs ΔpolyA and A9.
Replicon Δvar, lacking the entire variable region, was constructed
in the sameway as ΔpolyA and A9, with the same primers (F-XbaI and
R-AatII) and restriction enzymes, but using the previously described
plasmid clone pNd/3′Δ10795 (Mandl et al., 1998), which has a deletion
from nucleotide 10378 to 10795, as template.
The reporter replicons in this study that contained expression
cassettes in the 3′-NCR, (IRES-eGFP, IRES-ME, IRES(A771C)ME and
IRES(26A)ME) were obtained by taking previously described plasmids
containing these cassettes and replacing a fragment extending from
a SalI site preceding the T7 promoter to a ClaI site at nucleotide
3155 (in the NS1 coding region) with the corresponding region from
C17ﬂuc-TaV2A. The following plasmids were used as backbones for
these constructs: pTNd/ΔME-EGFP (Gehrke et al., 2005), TBEV-bc
(Orlinger et al., 2006), TBEV-bc(A771C) and TBEV-bc(26A) (Orlinger
et al., 2007).
To obtain the replicons 12xMS2 and 24xMS2, we took advantage of
the plasmids pTNd/ΔME_12xMS2 and pTNd/ΔME_24xMS2, in which
the variable region of the 3′-NCR within the previously described
plasmid pTNd/ΔME (Gehrke et al., 2003) had been replaced by cassettes
containing12or 24 repeats of a stem–loopRNAstructure (19nucleotides
each) that is speciﬁcally recognized by the MS2 bacteriophage coat
protein (Bertrand et al., 1998). Construction of the plasmids pTNd/
ΔME_12xMS2 and pTNd/ΔME_24xMS2 is described in detail in an
accompanying paper byMiorin et al. (submitted). The 3′-NCR containing
the repeats was substituted for the corresponding fragment in the
C17ﬂuc-TaV2A construct using restriction sites for ClaI (position 3155)
and NheI (at the 3′ end).
All plasmids were propagated in E. coli strain HB101, and prep-
arations were made using commercial puriﬁcation systems (Qiagen).
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The sequences of the constructs were conﬁrmed using an automated
DNA sequencing system (PE Applied Biosystems, GA3100).
In vitro RNA synthesis and transfection
Procedures for in vitro transcription and transfection of BHK-21 cells
by electroporation were performed as reported in previous studies
(Mandl et al., 1997). Uncapped and capped RNA with m7GpppG cap
analogue were synthesized using reagents from the T7 Megascript kit
(Ambion) according to the manufacturer's protocol. After the tran-
scription reaction, template DNA was digested with DNAseI, puriﬁed,
and separated from unincorporated nucleotides using an RNeasy®Mini
Kit (Qiagen). The integrityof theRNAwascheckedbyelectrophoresis in a
1% agarose gel containing 6% formalin. RNA was quantiﬁed by spectro-
photometric measurement, and equal amounts of RNA (corresponding
to approximately 1.9×1012 copies) were used for all transfections.
RNA for expression of Renilla luciferase as a cotransfection control
was made by ﬁrst linearizing plasmid phRL-SV40 with BamHI and
purifying it by phenol-chloroform treatment. A 6-µg aliquot of this
DNA was then used to make capped RNA, using the same procedures
for synthesis, puriﬁcation, and quantitation that were used for the
replicon RNA.
BHK-21 cells (ATCC CL10) were grown at 37 °C with 5% CO2 in
Eagle's minimal essential medium (EMEM) (Sigma) supplemented
with 5% fetal calf serum (FCS), 1% glutamine, and 0.5% neomycin. The
cells were electroporated using a GenePulser apparatus (Bio-Rad)
as described previously (Mandl et al., 1997). After transfection, the
growthmediumwas replaced by amaintenance medium consisting of
EMEM without phenol red (Cambrex), containing 1% FCS.
Luciferase assays
A Dual-Glo™ Luciferase Assay System (Promega) was used
according to the manufacturer's instructions to simultaneously
measure both ﬁreﬂy and Renilla luciferase activity. After electropora-
tion of BHK-21 cells with RNA and/or DNA, cells were washed once
with growth medium (EMEM without phenol red, Cambrex) contain-
ing 5% FCS and counted. A maximum of 60,000 cells were seeded onto
96-well plates (Perkin Elmer), and triplicate wells were lysed at in-
dividual time points, followed by measurement with a Victor Light
Luminometer (Perkin Elmer). The primary data are given in relative
light units (RLUs).
For normalization of the ﬁreﬂy luciferase values, replicon RNA
(1.9×1012 copies) containing the ﬁreﬂy luciferase gene was cotrans-
fected with either 6 µg of RNA that had been transcribed in vitro from
phRL-SV40 (encoding Renilla luciferase) as a standard for the early
time points (3 hours) (h), or 6 µg of phRL-SV40 DNA for later time
points (13–96 h). In addition, a separate “control standard” consisting
of BHK-21 cells transfected with the control nucleic acid alone was
included in each experiment, and the mean value of the Renilla
luciferase activity of these cellswas determined at each time point. The
ratio of the uncorrected luciferase activitymeasured for the RNAversus
the DNA controls differed less than two-fold between individual
transfection experiments indicating that only little variability was
introduced due to the usage of two different controls within a single
time course experiment. The same electroporation conditions were
used for DNA and RNA samples and yielded consistently high
efﬁciencies between 50 and almost 100% of the transfected cells as
determined by immunoﬂuorescence or FACS. To calculate the normal-
ized ﬁreﬂy luciferase activity, the measured Renilla luciferase activity
from each cotransfected sample was divided by the corresponding
control standard value to obtain a normalization factor by which the
measuredﬁreﬂy luciferase value of thatwellwas divided. To correct for
variability between different plates, the control standards from each
plate were normalized to a single standard to obtain a factor by which
the ﬁreﬂy luciferase values for that plate were then multiplied. In this
way, corrections could be made for differences in transfection ef-
ﬁciencyaswell as total cell count at different timepoints. The corrected
data are presented as “normalized RLUs”.
Immunoﬂuorescence assay
Approximately 1×105 cells were seeded onto individual glass cover
slips in 24-well plates and suppliedwith growthmediumsupplemented
with 5% FCS. The growth medium was replaced 20 h posttransfection
with maintenance mediumwith the FCS content reduced to 1% to slow
cell growth. Immunoﬂuorescence stainingwas performed on day 3 after
electroporation. Cells were permeabilized by acetone–methanol (1:1)
ﬁxation, and the presence of NS1 protein was visualized by incubation
with a mouse anti-NS1 monoclonal antibody (Iacono-Connors et al.,
1996) and FITC-conjugated anti-mouse IgG antibody (Sigma). The eval-
uation of the immunoﬂuorescence staining was performed by visual
inspection using a Nikon Microphot microscope.
Immunoblotting
Cells grown in 12-well plates were harvested 48 h after electro-
poration, washed twice with PBS, lysed in 100 µl lysis buffer (1 M Tris,
2% SDS, 10% glycerin and 0.05% bromophenol blue), and boiled for
7 min at 95 °C. Ten-microliter aliquots of the cell lysates were
separated under SDS-denaturating conditions on a 15% polyacryla-
mide gel, and proteins were blotted onto a PVDFmembrane (Bio-Rad),
which was then blocked overnight at 4 °C using PBS containing 1%
BSA and 0.2% Tween-20 (PBS-T). The membranes were probed with
primary antibodies to TBEV NS1 (1:1000 in PBS-T) or anti-luciferase
polyclonal antibody (Promega) (1:1000) for 2 h at room temperature
(RT). Both peroxidase-conjugated rabbit anti-mouse IgM (1:3000)
(Amersham Biosciences) and donkey anti-goat (1:7500) (Promega)
secondary antibodies were used, and FAST™ 3,3-diaminobenzidine
tablets (Sigma) were used for detection.
Quantitative PCR
Intracellular RNA levels were monitored by quantitative real-time
PCR as described previously (Koﬂer et al., 2006). Brieﬂy, BHK-21 cells
were electroporatedwith equimolar amounts of RNA. Then, to remove
noninternalized RNA, cells were washed twice with growth medium
containing 5% FCS and seeded into 25-cm2 tissue culture ﬂasks. Cells
were harvested at different time points and counted using a Casy 1 TT
cell counter (Schärfe system). Cytoplasmic RNA was extracted from a
deﬁned number of cells using an RNeasy® Mini Kit (Qiagen) and
subjected to quantitative PCR (PE Applied Biosystems), as described
elsewhere (Koﬂer et al., 2006).
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Abstract 
 
MicroRNAs (miRNAs) are a class of small, non-coding RNAs that play a pivotal role in 
the regulation of post-transcriptional gene expression in a wide range of eukaryotic 
organisms. Although DNA viruses have been shown to encode miRNAs and exploit the 
cellular RNA silencing machinery as a convenient way to regulate viral and host gene 
expression, it is generally believed that this pathway is not available to RNA viruses that 
replicate in the cytoplasm of the cell because miRNA biogenesis is initiated in the nucleus. In 
fact, among the more than 100 viral miRNAs that have been experimentally verified so far, 
none is derived from an RNA virus. Here, we show that a cytoplasmic RNA virus can indeed 
encode and produce a functional miRNA. We introduced a heterologous miRNA-precursor 
stem-loop sequence element into the RNA genome of the flavivirus tick-borne encephalitis 
virus, and this led to the production of a functional miRNA during viral infection without 
impairing viral RNA replication. These findings demonstrate that miRNA biogenesis can be 
used by cytoplasmic RNA viruses to produce regulatory molecules for the modulation of the 
transcriptome.  
 
 
Introduction 
 
MicroRNAs (miRNAs) are a class of short (~21-25 nucleotides), single-stranded 
noncoding RNA molecules that play a critical role in many cellular processes, such as cell 
development, differentiation, apoptosis and oncogenesis (1-3). They exert their suppressive 
activity on gene expression by guiding the RNA-induced silencing complex (RISC) to 
complementary RNA stretches within a specific messenger RNA. The biosynthesis of the 
vast majority of microRNAs involves the sequential action of two RNAse III enzymes, Drosha 
and Dicer (4). A larger RNA precursor containing a characteristic miRNA hairpin structure is 
transcribed in the nucleus. This so-called primary microRNA is recognized by Drosha (acting 
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with cofactor DGCR8) and cleaved into a ~70-nt stem-loop RNA intermediate (precursor-
miRNA, pre-miRNA), which is then transported by exportin-5 to the cytoplasm, where it 
undergoes processing by Dicer, and gives rise to a mature, single-stranded microRNA (5-
11). 
 The number of identified microRNAs in plants and animals is rapidly increasing, and 
more than 700 miRNAs are known so far in humans (12). The first microRNAs expressed 
from human viruses were discovered in 2004 (13). Since then, more than 100 viral 
microRNAs have been described, but up to now, all of them have been derived from viruses 
with a nuclear DNA stage in their replication cycle, mainly of the herpesvirus family (12,14). 
Although computer algorithms have also predicted the existence of microRNA hairpins in 
viruses with RNA genomes (15), a study involving the cloning of small RNAs from cells 
infected with two positive-strand RNA viruses, hepatitis C virus (HCV) and yellow fever virus 
(YFV), did not result in the identification of any RNA virus-derived small interfering RNAs 
(siRNAs) or miRNAs (16). However, Parameswaran et al. quite recently identified virus 
derived smallRNAs (vsRNAs) in a wide range of vertrebrate cells infected with RNA viruses, 
such as Dengue, West Nile and Hepatitis C virus (17). Although the experimental high-
troughput approach taken in that study did neither elucidate the exact precursor structures of 
the discovered vsRNAs nor provide evidence for their functionality, it raised the possibilty 
that these vsRNAs might also include virus-derived microRNAs. 
In the present study, we investigated whether RNA viruses are fundamentally capable 
of producing functional miRNA, by inserting a known miRNA element into the genome of an 
RNA virus whose life cycle is confined to the cytoplasm of the host cell. Thereby we show 
that a functional microRNA can indeed be produced during infection without imparing viral 
RNA replication. 
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Material and Methods 
 
Viruses and cells 
Western subtype TBEV strain Neudoerfl, which has been characterized in detail, 
including the determination of its entire genomic sequence (18,19), (GenBank accession no. 
U27495), was used as the wild-type control in all infection experiments, and all mutants 
described in this study were derived from this strain. 
The EBV miR-BART2 sequence was obtained from genomic DNA of human 
herpesvirus 4 (Epstein-Barr virus (20), GenBank accession no. V01555). 
BHK-21 cells were grown at 37 °C with 5% CO2 in Eagle’s minimal essential medium 
(Sigma) supplemented with 5% fetal calf serum (FCS), 1% glutamine, and 0.5% neomycin 
(growth medium) and were maintained in Eagle’s minimal essential medium supplemented 
with 1% FCS, 1% glutamine, 0.5% neomycin, and 15 mM HEPES, pH 7.4 (maintenance 
medium). 
 
Mutant construction 
All viral constructs described in this study are derivatives of pTNd/c, an infectious 
cDNA clone of TBEV strain Neudoerfl (21). To create variants containing the miR-BART2 
precursor stem-loop and flanking EBV sequence, DNA was amplified from EBV B95-8 
genomic DNA using primers 5’-ATCGACCGGTATGCCACCTCCCTGCCTG-3’ and 5’-
CGATACCGGTGCGTGGCCCGTGGATCTG-3’. The PCR product was digested with AgeI 
and ligated with AgeI-digested reporter replicon construct C17, yielding C17 BART(+) or C17 
BART(-), depending on the orientation of the insert. C17 is a modified version of the 
previously described construct C17fluc-TaV2A (22) in which the firefly luciferase start codon 
ATG was deleted. C17 matBART(+) was constructed by first annealing oligonucleotides 5’-
CCGGACTATTTTCTGCATTCGCCCTTGCGT-3’ and 5’-
CCGGACGCAAGGGCGAATGCAGAAAATAGT -3’, resulting in a double-stranded DNA 
fragment with AgeI overhangs, and then ligating this fragment with AgeI-digested C17 
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plasmid DNA. Full-length infectious cDNA clones were constructed by excising an XbaI/NheI 
fragment from each C17 replicon and inserting it into the corresponding site of XbaI/NheI-
digested pTNd/c.  
The non-replicating C17 variant C17 BART(+)GAA was constructed by replacement of 
the NS5 coding sequence of C17 BART(+) with an KpnI/XbaI-digested fragment of the 
previously described reporter replicon mutant NS5-GAA. The sequences of all constructs in 
this study were confirmed using an automated DNA sequencing system (PE Applied 
Biosystems, GA3100). 
 
Reporter constructs and luciferase assays 
To construct the luciferase reporter plasmids psiCHECK1-BART2 and psiCHECK2-
BART2, oligonucleotides 5’-TCGAGCGCAAGGGCGAATGCAGAAAATAGT-3’ and 5’-
GGCCACTATTTTCTGCATTCGCCCTTGCGC-3’, containing XhoI and NotI overhangs, were 
annealed and ligated into the multiple cloning site of psiCHECKTM-1 and psiCHECKTM-2 
(Promega).   
The Dual-GloTM Luciferase Assay System (Promega) was used according to the 
manufacturer’s instructions to measure both firefly and Renilla luciferase activity 
simultaneously. For experiments with infectious viruses, cells were electroporated with 6 µg 
psiCHECK2-BART2 plasmid DNA using a Gene Pulser apparatus (Bio-Rad). One day after 
electroporation, 60,000 cells/well were seeded in 96-well plates for subsequent infection in 
triplicate with wild-type and mutant virus at an MOI of 10. Renilla and firefly luciferase levels 
were determined immediately after infection and at 24 and 48 hours postinfection. For 
experiments using non-infectious replicons, cells were coelectroporated with equimolar 
amounts of in vitro-transcribed replicon RNA (corresponding to approximately 1.2 x 1012 RNA 
copies) and 6 µg psiCHECK1-BART2 plasmid DNA. Procedures for RNA in vitro transcription 
and electroporation of BHK-21 cells were performed as reported in previous studies (21,22). 
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Immunofluorescence assay 
Approximately 1 x 105 cells were seeded onto individual glass cover slips in 24-well 
plates prior to infection (TNd/c mutant set) or after transfection (C17 mutant set). 
Immunofluorescence staining was performed 24 hours after infection with TNd/c mutants or 
48 hours after transfection with replicon RNA. Cells were permeabilized by acetone-methanol 
(1:1) fixation, and viral proteins were detected by incubation with rabbit anti-TBEV serum and 
a fluorescein-isothyocyanate-conjugated anti-rabbit antibody (Jackson ImmunoResearch 
Laboratories).  
 
Northern blot analysis 
miRNA-BART2 northern blotting: Total RNA was extracted using a mirVana miRNA 
Isolation Kit (Ambion) following the vendor’s recommendations. 20 µg of total RNA per 
sample was electrophoresed through a 12% urea-polyacrylamide gel, which was stained with 
ethidium bromide for visualization of bands and then electroblotted to Hybond XL nylon 
membranes (GE Healthcare). A mirVana miRNA Probe Construction Kit (Ambion) and 
[alpha-32P] CTP (Hartmann Analytic) were used to construct a radioactive RNA probe (5’-
GCAAGGGCGAAUGCAGAAAAUA-3’) complementary to EBV miR-BART2-5p. Blots were 
hybridized overnight in PerfectHybTM Plus (Sigma) hybridization buffer at 50°C and then 
washed twice with 5x SSC + 1% SDS and twice for 15 min with 1x SSC + 1% SDS prior to 
signal detection on a phosphorimager. Cells electroporated with synthetic miRNA (Pre-miR™ 
miRNA Precursor Molecules, Ambion) at a concentration of 30 nm were used as positive 
controls. 
 Northern blot of subgenomic RNA: One µg of total RNA, extracted from BHK-21 
cells using an mirVana miRNA Isolation Kit (Ambion), was subjected to denaturing gel 
electrophoresis using a Northern MaxGly Kit (Ambion) and transferred to a positively charged 
nylon membrane (BrightStar Plus, Ambion) according to the manufacturer’s 
recommendations. Two different probes were constructed by in vitro transcription 
(MAXIscript T7 Kit, Ambion) using biotinylated UTP (Ambion). Templates for in vitro 
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transcription were generated by PCR amplification of pTNd/c-BART(+) DNA using the 
following T7 promoter primers: 5’- CAGGGGTGAGGAATGCCCCCAGA-3’ and 5’- 
TAATACGACTCACTATAGGGCGGGTGTTTTTCCGAGTCAC-3’, yielding a probe 
complementary to the core 3’-NCR of TBEV, and 5’-ATGCCACCTCCCTGCCTGGTGGAC-3’ 
and 5’-TAATACGACTCACTATAGGGCGTGGCCCGTGGATCTGTGAA-3’,  yielding a probe 
specific for  the miR-BART2 sequence insertion, including the EBV flanking regions. 
Hybridization and washing steps were performed according to the manual, and these were 
followed by a non-isotopic detection procedure (Bright Star Biodetect Kit, Ambion). 
 
Real-time RT PCR 
Total RNA from infected cells was extracted using a mirVana miRNA Isolation Kit 
(Ambion). TaqMan MicroRNA Assays (Applied Biosystems) specific for EBV BART2-5p and 
U6 snRNA (endogenous control) were performed according to the manufacturer’s protocol 
using an ABI 7300 Real-Time PCR System (PE Applied Biosystems).   
Relative quantitation was carried out using the 2-∆∆T method (23) for infected versus 
uninfected cells.  
 
Virus production, passaging and focus assay 
For the production of infectious virus particles, BHK-21 cells were transfected with 
equal amounts of in vitro-transcribed full-length RNA. The supernatant from the transfected 
cells was collected 48 hours postinfection and cleared by centrifugation. Various dilutions 
were applied to confluent cell monolayers to determine the number of focus-forming units 
(ffu). Fifty hours postinfection, cells were fixed with acetone-methanol (1:1) and treated with 
polyclonal rabbit anti-TBEV serum. Antibody-labeled cells were detected using an 
immunoenzymatic reaction consisting of successive incubations with goat anti-rabbit 
immunoglobulin G-alkaline phosphatase and the corresponding enzyme substrate 
(SigmaFast Red TR/Naphtol AS-MX tablets). To analyze the genomic stability of the viral 
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mutants and to increase the titer, viruses for infection experiments were passaged at least 5 
times, using a 1:5,000 dilution of the supernatant.  
 
Results 
 
Construction of a cytoplasmic RNA virus encoding a viral miRNA.  
 For these experiments, we used tick-borne encephalitis virus (TBEV), a human 
pathogen of the genus Flavivirus, family Flaviviridae. Like all members of this family of 
positive-strand RNA viruses, the replication cycle of TBEV takes place in the cytoplasm. Its 
genome consists of a single RNA molecule of approximately 11 kb in length, which also 
serves as a messenger RNA, encoding a single polyprotein precursor that is processed to 
form three structural proteins (C, prM, E), which together with the genomic RNA compose the 
virion, and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) that 
are necessary for replication (Fig. 1A) (24-26).  
The 3’-noncoding region (3’-NCR) of TBEV has been shown to tolerate the insertion of 
heterologous sequence elements (22). We took advantage of this flexibility to insert the miR-
BART2 hairpin precursor from the herpesvirus Epstein-Barr virus (EBV) between the variable 
and core regions of the 3’-NCR of a wild-type TBEV strain (TNd/c, Fig. 1B,C). MiR-BART2 
downregulates expression of the EBV DNA polymerase BALF5, and this is thought to 
prevent the transition from latent to lytic replication (16,27,28). To favor proper formation of 
the stem-loop secondary structure, which is crucial for recognition by the classical miRNA-
processing machinery (6,29,30), we decided to add flanking EBV sequence on either side of 
the hairpin. We generated three different BART mutants. The EBV miR-BART2 precursor 
was introduced in the plus-strand (messenger-sense) orientation (TNd/c BART(+)) and also 
as the reverse complement (TNd/c BART(-)) to allow a potentially functional miRNA 
precursor to be formed at the 5’end of the negative-strand (antisense) copy of the viral RNA 
during replication. Bioinformatic secondary structure analysis prior to construction of these 
mutants prompted us to add 30 nt of original genomic EBV sequence on either side of the 
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hairpin, resulting in a tolerable maximum of 128 nt for the full-hairpin insertions. In a third 
construct, only the “mature” miR-BART2 sequence, devoid of any EBV-derived flanking 
sequences or hairpin structure elements, was inserted (TNd/c matBART(+)). To assess the 
capability of these TBEV BART mutants to replicate and be translated, RNA from the 
mutants and wild-type TBEV was made by in vitro transcription and introduced into BHK-21 
cells by electroporation. Immunofluorescence staining with an anti-TBEV serum 24 hours 
after transfection showed that all three mutants were able to replicate and express viral 
proteins (Fig. 1C), indicating that the inserted microRNA hairpin structure elements did not 
impair viral RNA replication or protein expression.  
Next, we examined the stability of the heterologous sequence elements in a passage 
experiment on BHK-21 cells. After five rounds of sequential infection with diluted supernatant 
from the previous passage, no sequence changes could be detected in the inserted miR-
BART2 sequences or the flanking elements. The only mutations observed were ones that 
occurred in the viral envelope protein E and were of a type previously associated with cell 
culture adaptations (Table S1) (31,32). Taken together, these results demonstrated that the 
insertion of a microRNA hairpin precursor in either orientation into the RNA genome of this 
flavivirus was genetically stable and compatible with viral growth. 
 
Functional activity of the inserted miRNA. 
 As a tool to measure the functional activity of miR-BART2, we established a dual-
luciferase reporter assay. The original miR-BART2 target sequence was inserted 
downstream of the translational stop codon of the Renilla luciferase (Rluc) coding sequence 
of the siRNA evaluation vector psiCHECKTM-2, yielding a construct encoding an Rluc mRNA 
fused to a BART2 target site, termed psiCHECK2-BART2 (Fig. 1D). Firefly luciferase (fluc) 
on the same plasmid, driven from a second promoter, served as an internal control. As 
expected, Rluc expression from this construct was suppressed in a dose-dependent manner 
upon transfection with synthetic miR-BART2 (Fig. S1A). To investigate whether the viral 
mutants TNd/c BART(+), TNd/c BART(-) and TNd/c matBART(+) were able to downregulate 
M a n u s c r i p t  2  | 63 
 
reporter gene expression, BHK-21 cells were transfected with psiCHECK2-BART2 and 24 
hours thereafter infected with BART mutants or wild-type virus. TNd/c BART(+) strongly 
suppressed reporter gene expression at 24 and 48 hours postinfection (Fig. 2A). The 
observed reduction by approximately 50% is equal to the effect seen with the natural miR-
BART2 target BALF5 protein in EBV-infected cells with forced miR-BART2 expression (27). 
In contrast, infection of cells with TNd/c BART(-) or TNd/c matBART(+) did not decrease 
reporter gene expression.  
 
Time course of miR-BART2 generation during infection.  
 To obtain direct evidence for the formation of miR-BART2, total RNA was isolated from 
infected cells and subjected to northern blot analysis 24 hours after infection (Fig. 2B). 
Consistent with the data from the luciferase assay, mature miRNA and the corresponding 
pre-miR were readily detected in cells infected with TNd/c BART(+), but not in samples of the 
other mutants or wild-type virus. To establish a time course of miRNA formation in infected 
cells, we performed a TaqManTM MicroRNA Assay (Fig. 2C). In cells infected with TNd/c 
BART(+), levels of miR-BART2 increased within 24 hours to a maximum plateau level, 
whereas the signal detected for TNd/c BART(-) and TNd/c matBART(+) remained at or close 
to background levels. 
 
Dependence of miRNA production on replication of viral RNA.  
 The experiments described above consistently indicated that significant amounts of 
functional miR-BART2 were generated with TNd/c BART(+) and prompted a more detailed 
investigation of the relationship between RNA replication and miRNA formation. For this 
purpose, we prepared an analogous set of replicons (C17 BART(+), C17 BART(-) and C17 
matBART(+)) based on the TBEV reporter replicon C17fluc-TaV2A, a construct in which the 
viral structural proteins had been replaced by an in-frame insertion of the firefly luciferase 
gene (Fig. 3A) (22). Additionally, we designed a replication-negative variant of C17 BART(+) 
with a GDD-to-GAA mutation in the active site of the viral polymerase, termed C17 
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BART(+)GAA (Fig. 3A). Immunofluorescence staining with an anti-TBEV antiserum 48 hours 
after transfection confirmed that all of the replicons encoding a functional RNA polymerase 
were able to replicate and express viral proteins (Fig. 3A, bottom).  
 Replication of these replicons was monitored by measurement of fluc activity in 
transfected BHK-21 cells, and this revealed that the insertion of the miRNA sequence (in 
either orientation or in its mature form) did not alter the level of RNA replication relative to the 
parental C17 replicon (Fig. 3B). As expected, and consistent with the immunofluorescence 
results, C17 BART(+)GAA was negative for RNA replication. To confirm that miRNA 
formation from these replicons mirrored the findings with infectious virus, functional miR-
BART2 activity was assayed by measuring Rluc reporter gene repression (Fig. 3C; Fig S2 for 
a complete data set) using a modified reporter plasmid lacking firefly luciferase, psiCHECK1-
BART2 (Fig. 3D). C17 BART(+) clearly suppressed reporter gene activity, and the presence 
of the miRNA was additionally confirmed in a northern blot assay (Fig. 3E). In contrast, no 
activity and no miRNA was observed for C17 BART(-), C17 matBART(+) or the parental 
control C17. Notably, the replication-deficient control C17 BART(+)GAA also did not 
suppress Rluc expression or generate detectable miRNA (Fig. 3C,E).  
 
Discussion 
 
 This is the first study that describes the generation of a functional microRNA from a 
cytoplasmic RNA virus. This observation is unexpected since two theoretical barriers are 
generally thought to impede miRNA biogenesis for this class of viruses: First, in contrast to 
DNA and retroviruses, the replication cycle of cytoplasmic RNA viruses takes place in the 
cytoplasm, away from the nucleus where Drosha resides and initiates the processing of the 
miRNA hairpin structure for a majority of all known microRNAs. Secondly, even if the 
microRNA precursor could be liberated from an RNA virus genome, this excision event would 
be expected to destroy copies of the viral genome and thereby reduce RNA replication 
efficiency.  
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A detailed follow-up study has to be carried out now, to clarify, how and where the 
microRNA is generated in our system, and which key players of the classical microRNA 
biogenesis pathway are involved in this process. Regardless of the mechanism, however, 
our results demonstrate that these barriers are not absolute and that they can eventually be 
circumvented. 
One possible way in which this could occur is that viral infection might lead to a partial 
breakup of cellular compartmentalization or to protein retrafficking, allowing the Drosha 
complex to act in the cytoplasm. Another possibility is that a fraction of the flavivirus RNA 
containing the miRNA-BART2 precursor enters the nucleus. Many positive- and negative-
strand RNA viruses with a cytoplasmic replication cycle have been reported to alter nuclear-
cytoplasmic trafficking to expedite viral growth (33), and the presence of flaviviral RNA in the 
nucleus has been suggested in a recent study (34). It therefore seems justifiable to speculate 
that Drosha and a fraction of the viral RNA containing the microRNA hairpin structure are 
present in the same cellular compartment at some point during infection. First experiments, 
performed to unravel the role of Drosha, point in this direction and do not suggest a Drosha-
independent pathway (data not shown). As it is becoming clear since recently that also non-
canonical pathways can lead to the generation of functional microRNAs (5), it remains 
possible, however, that the activity of this enzyme is bypassed. One such pathway, in which 
miRNA precursors are fed into the miRNA maturation pathway without a contribution of 
Drosha, is the mirtron pathway (35-37). In this case, pre-miRNAs are formed from 
debranched introns during mRNA splicing.  
 One of the most important findings of our study is that while active viral replication was 
required for production of miRNA-BART2, the presence of the functional miRNA precursor 
element in the TBEV genome did not have a measurable negative impact on RNA 
replication. Remarkably, in a recent study, it was found that several flaviviruses produce a 3’-
terminal noncoding RNA fragment that accumulates in infected cells due to incomplete 
degradation of viral genomic RNA (38). This highly structured, nuclease-resistant RNA was 
shown to increase both virus replication and virus-induced cytopathogenicity, although the 
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reason for this is still unknown. This observation supports the idea that fragmentation 
processes can also be beneficial and that RNA viruses can indeed use such mechanisms to 
generate smaller RNA molecules with biological activity without the need for subgenomic 
promoters. In further experiments, we found that TBEV-infected cells also contain relatively 
large amounts of a 3’-terminal subgenomic RNA and that the amount of this RNA present in 
the cell is not altered by the insertion of the BART2 sequence element (Fig. S3).   
 We also found that although insertion of the natural miRNA-BART2 hairpin precursor, 
with flanking sequences from the EBV genome, into the TBEV 3'-NCR in the plus-strand 
(messenger-sense) orientation led to production of a mature, functional miRNA, insertion of 
only the portion corresponding to mature miRNA-BART2 did not. This further emphasizes 
that the resulting mature microRNA was not simply a remaining piece of randomly degraded 
viral RNA but indeed the product of an active miRNA processing pathway. 
  Interestingly, the insertion of the same miRNA-BART2 precursor in the antisense 
orientation did not result in miRNA production. Since all of the constructs tested were 
genetically stable over multiple passages and apparently had no effect on the efficiency of 
viral RNA replication, we conclude that there must be specific mechanistic reasons for the 
requirement of the precursor element to be in the positive-sense orientation. First, the 
replication of flaviviruses is asymmetrical, meaning that viral plus-strands accumulate in 
around tenfold excess over the corresponding genome-length minus-strands (24). Second, 
the minus-strand RNA template may be inaccessible to the microRNA machinery when it is 
in the ER-associated viral replication complex. Recent biochemical analysis has suggested 
that the flavivirus replication complex resides in virus-induced double-layered membrane 
compartments (39). Therefore, it seems reasonable that the minus-strand remains shielded 
from other cellular compartments and enzymes. The plus-strand, in contrast, is forced to 
leave the site of replication to gain access to the cellular translation machinery. 
The results of this study demonstrate that, contrary to current assumptions, RNA 
viruses, at least under some circumstances, can carry functional microRNA elements. It is 
therefore not unlikely that among the vast assortment of diverse RNA viruses found in 
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nature, some will be found that encode miRNAs and even use them as part of their 
replication strategy to regulate viral or host gene expression. The recent discovery of RNA 
virus-derived small RNAs in a wide range of host cells (17)  is in good agreement with this 
hypothesis and it is tempting to speculate that at least some of them represent such RNA 
virus-derived miRNAs. 
We hope that our report stimulates a more comprehensive search for natural 
microRNAs in many different RNA viruses. But regardless of whether or not microRNAs are 
found to play a physiological role in their biology, our study provides first direct evidence that 
their generation is mechanistically possible. This knowledge opens up new avenues for the 
rational design of RNA virus mutants and vectors encoding this important class of regulatory 
molecules. 
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Figure legends 
 
Figure 1. 
TNd/c BART mutants and reporter plasmid psiCHECK2-BART2. (A) Genome 
organization of wild-type TBEV virus strain Neudoerfl (TNd/c). 5’-NCR, 5’-noncoding region; 
3’-NCR, 3’-noncoding region. The positions of the "variable" and conserved "core" regions of 
the 3'-NCR are indicated. (B) EBV miR-BART2 precursor in the predicted secondary 
structure (miRBase accession number: MI0001068) flanked by 30 nt of EBV B95-8 sequence 
on either side. The sequence of the precursor of miR-BART2 is highlighted in red and blue, 
with the red region corresponding to the mature miR-BART2. (C) Top. Schematic diagram of 
the 3’-NCR of parental virus TNd/c and the derived TNd/c BART mutants. Below. 
Immunofluorescence (IF) staining of infected cells with rabbit anti-TBEV serum 24 hours 
postinfection. (D) Mature miR-BART2 (red) and the corresponding target sequence in the 3’-
UTR of the EBV BALF5 mRNA (green) that was inserted into the 3’-UTR of the Renilla 
luciferase (Rluc) mRNA gene of the parental vector psiCHECK-2. Firefly luciferase (fluc) 
expressed from the HSV-TK promoter served as an internal standard.  Promoters are 
indicated by flags: SV40, simian virus 40; HSV-TK, herpes simplex virus thymidine kinase. 
Diagrams are not drawn to scale. 
 
Figure 2.  
A functional miRNA is produced during infection with TBEV mutant TNd/c BART(+). 
(A) Relative Rluc activity after infection with TNd/c BART mutants. BHK-21 cells were 
transfected with psiCHECK2-BART2 and 24 hours thereafter infected with viral mutants at an 
MOI of 10.  Values represent Rluc expression levels relative to the infection with wild-type 
virus. Error bars indicate standard deviations of three experiments, each measured in 
triplicate. (B) Northern blot analysis of intracellular RNA 24 hours after infection using a 
radioactive complementary RNA probe specific for the mature miR-BART2 sequence. Cells 
electroporated (EP) with synthetic miRNA-BART2 (syn. miRNA) served as a positive control. 
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(C) Time course analysis of miR-BART2 expression in BHK-21 cells infected at an MOI of 
10. At the indicated time points, total RNA of infected cells was isolated and subjected to a 
TaqManTM MicroRNA Assay specific for mature miR-BART2. U6 snRNA served as an 
endogenous control. The ΔCT value of uninfected cells at time point 0 was used as a base 
value to calculate fold change in expression by the comparative CT method. 
 
Figure 3. 
RNA replication is necessary for but not affected by miRNA biogenesis. (A) Top. 
Schematic diagram of parental luciferase reporter replicon C17, which contains the first 17 
aa of the capsid protein and has the rest of the structural proteins replaced by firefly 
luciferase (fluc). The 3’-NCR of each replicon is identical to that of the corresponding TNd/c 
virus mutant (Fig. 1C). Replication-negative C17 BART(+)GAA differs from C17 BART(+) by 
a GDD-to-GAA mutation in the polymerase active site of the viral NS5 protein. Below. 
Immunofluorescence (IF) staining with rabbit anti-TBEV serum 48 hours posttransfection. (B) 
Replication efficiencies of the C17 BART mutant set monitored by firefly luciferase activity in 
BHK-21 cells. Error bars represent the standard deviation of three independent experiments, 
each measured in triplicate. (C) Relative Rluc activity in BHK-21 cells co-transfected with 
miR-BART2 reporter plasmid psiCHECK1-BART2 and the C17 BART mutants C17 BART(+) 
and C17 BART(+)GAA. Rluc levels are shown as a percentage of the level obtained with the 
parental replicon C17. Error bars represent the standard deviation calculated from a 
minimum of three independent experiments, each measured in triplicate. (D) Schematic 
diagram of the reporter plasmid psiCHECK1-BART2, which contains the miR-BART2 target 
sequence fused to the Renilla luciferase coding sequence under the control of an SV40 
promoter.  (E) Relative Rluc activity of C17 BART mutants at 48 hours posttransfection (top) 
and northern blot analysis (below) of the same intracellular RNA preparation used in the Rluc 
assay. The positions of the precursor and the mature miRNA are indicated by arrows. Total 
RNA of cells electroporated with synthetic miR-BART2 (syn. miRNA) served as a control. 
Diagrams (A) and (D) are not to scale. 
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Figure legends – Supplementary Material 
 
Figure S1. 
miR-BART2 specifically downregulates the expression of reporter mRNAs fused to the 
corresponding miR-BART2 target site. Time course of Renilla luciferase (Rluc) activity in 
cells transfected with the reporter constructs psiCHECK2-BART2 (A) and psiCHECK1-
BART2 (B), either individually or together with synthetic pre-miR-BART2 precursor molecules 
at a concentration of 1mM or 30 nM. In the case of psiCHECK2-BART2, the Rluc light units 
were normalized to those of firefly luciferase (fluc) expressed from a different promoter on 
the same plasmid as an internal standard (Fig. 1D). psiCHECK-1-BART2 does not contain 
the fluc cistron (Fig. 3D). Data from control experiments using the parental vectors without 
miR-BART2 are shown at the right. Error bars represent the standard deviation of one 
experiment, measured in triplicate. 
 
Figure S2. 
Downregulation of Renilla luciferase in cells co-transfected with psiCHECK1-BART2 
and the C17 BART mutants (complete data set). Rluc levels are shown as a percentage of 
the level obtained with the parental replicon C17. Error bars represent the standard deviation 
from a minimum of three independent experiments, each measured in triplicate. 
 
Figure S3. 
A subgenomic RNA is produced from the 3’-terminal region of TNd/c and TNd/c 
BART(+) (A),  but the miR-BART2 sequence insertion is not contained on this fragment 
(B).  BHK-21 cells were infected with the indicated viruses at an MOI of 10, and total RNA 
was subjected to northern blot analysis using two biotinylated probes, one specific for the 
conserved "core" region of the 3’-NCR (probe A) and one specific for the miR-BART2 
sequence insertion including the flanking EBV elements (probe B). gRNA, genomic RNA; 
sgRNA, subgenomic RNA. 
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Abstract 
 
The RNA genomes of flaviviruses encode important cis-acting elements that are 
involved in the modulation of viral gene expression. A majority of these elements are located 
within the 5’- and 3’-terminal untranslated regions. In spite of their functional importance, 
sequence and secondary structures of these regulatory elements vary considerably among 
different members of the genus. Computer assisted prediction of the tick-borne encephalitis 
virus (TBEV) RNA secondary structure suggested the formation of 4 characteristic stem-loop 
(SL) elements in the first 180 nts of the viral genome, 5’-SL1, 5’-SL2, 5’-SL3 and 5’-SL4. 
Here, we applied a recently developed sensitive luciferase-based TBEV reporter system to 
unravel the role of 5’-SL2, 5’-SL3 and 5’-SL4 in viral input RNA translation and RNA 
replication. Mutations were introduced to manipulate the thermodynamic stability of these SL 
elements. We found that a balanced stability equilibrium of the 5’-SL2 element, which had 
previously been shown to contain the 5’-part of the TBEV genome cyclization sequence, was 
required for efficient viral RNA replication. In addition our data suggest that the formation of 
the 5’-SL3 element is critical for viral RNA replication. Although this structure contains the 
AUG start codon, its formation was not or only to a very small extent required for viral input 
RNA translation, whereas stabilization even had a negative effect on translation. Finally, our 
data indicate that 5’-SL4 may facilitate RNA translation and replication similar to the 
previously described cHP element in the genome of two mosquito-borne flaviviruses 
although it is situated at a different genomic position.  
 
 
Introduction 
 
Flaviviruses are small enveloped viruses with a positive-stranded ~11 kb RNA genome 
and comprise one of the three genera within the family Flaviviridae (1). The genus is further 
divided into three groups, based on the mode of transmission: mosquito-borne, tick-borne 
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and no-known-vector flaviviruses. The two major arthropod vector groups include important 
human pathogens such as West Nile virus (WNV), Dengue virus (DENV), yellow fever virus 
(YFV), Japanese encephalitis virus (JEV) - (all of them mosquito-borne) and tick-borne 
encephalitis virus (TBEV), the most important tick-transmitted flavivirus. TBEV is endemic in 
parts of Asia and Europe and causes thousands of cases of severe neurological illness every 
year (1,2). 
The RNA genome of all flaviviruses is a multifunctional molecule that serves as the 
sole mRNA for the translation into a single polyprotein, as template for minus-strand 
synthesis and as genomic RNA for incorporation into viral particles (1,3). To meet these 
versatile demands, the flaviviral RNA molecule is assumed to change its overall secondary 
structure at specific stages of the viral life cycle. Specific RNA sequence motifs in the 
terminal regions of the flavivirus genome may mediate these essential rearrangements (4). A 
well characterized aspect of these processes involves “cyclization” of the linear RNA 
molecule, in which base-pairing of a set of complementary RNA stretches present in the 
terminal regions of the genome induce the formation of a so-called panhandle-like structure 
(4-6). The viral replicase which specifically binds to a structure at the 5’-end of the genome is 
thus brought into close proximity of the 3’-terminus where it initiates synthesis of the 
negative-strand RNA molecule. Thus genome cyclization is essential for RNA replication of 
both mosquito-borne and tick-borne flaviviruses.  
Although genomes of both virus groups share a great deal of organizational similarity, 
there are significant differences in the sequence motifs that mediate cyclization. In mosquito-
borne flaviviruses, a 5’-cyclization sequence (5’-CS) within the capsid coding region binds to 
a complementary and highly conserved 3’-CS element in the 3’-NCR (4,5,7-9). In addition, a 
second interaction, outside of the 5’-3’-CS, has been reported (5,10,11), termed 5’-3’-UAR 
(upstream AUG region, as the 5’-element is located upstream of translation initiator AUG in 
the 5’-UTR). In contrast, in tick-borne flaviviruses a different set of sequence motifs mediates 
this process. The tick-borne 5’-CS-A element is located upstream of the viral start codon 
rather than downstream, and the complementary 3’-CS-A is placed at the bottom of the 
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terminal stem-loop 3’-SL1. Therefore this part of the 3’-SL1 cannot form when the genome 
has assumed the circularized conformation (12). Different from mosquito-borne flaviviruses, 
no functionality in RNA replication has been assigned to a second set of inverted sequence 
motifs (termed 5’- and 3’-CS-B) that had been predicted to be involved in long-range 
interactions by computational calculation (8,13,12). 
 Furthermore, a small RNA hairpin element in the capsid-coding region (capsid-coding 
region hairpin element, cHP) was shown for mosquito-borne flaviviruses (DENV and WNV) to 
enhance translation start codon selection and to be required for viral replication in a 
sequence-independent manner (14,15). Although a hairpin resembling the mosquito-borne 
cHP element is predicted to be maintained in tick-borne flaviviruses (5’-SL4), this structure is 
somewhat more distant from the AUG start codon and no function in viral gene expression 
has so far been demonstrated (12). 
Recently we have established a luciferase reporter replicon for TBEV which allows 
measurement and discrimination of mutational effects on RNA replication and/or translation 
(16). Here we applied this novel system to unravel the roles of three 5’-proximal TBEV 
secondary structure elements, termed 5’-SL2, 5’-SL3 and 5’-SL4 in viral translation and 
replication. We introduced stabilizing and destabilizing (as far as hairpin obviating) mutations 
in these conserved RNA stem-loop structures. In the case of 5’-SL2, which includes the 5’-
CS-A motif, RNA replication was found to strongly depend on its thermodynamic stability. 
Increase of stability completely abrogated RNA replication, presumably because it prevented 
5’-CS-A to induce genome cyclization. Surprisingly, destabilization of 5’-SL2 also impaired 
RNA replication without, however, affecting translation. Furthermore, a role in RNA 
replication was also revealed for 5’-SL3. Destabilization of 5’-SL3 impaired RNA replication. 
In contrast, stabilization of this structure, which contains the AUG start codon, diminished 
translation, but had only a minor effect, if any, on RNA replication. Finally, the data indicate 
an auxiliary function of the 5’-SL4 in viral translation initiation and RNA replication, 
reminiscent of the mosquito-borne cHP element. 
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Results and Discussion 
 
To independently analyze the role of 5’-SL2, 5’-SL3 and 5’-SL4 of TBEV (Fig. 1A) in 
viral replication and translation we constructed a set of mutants in the TBEV reporter replicon 
C17 (Rouha et al., submitted) which has the viral structural proteins replaced by an in-frame 
insertion of the firefly luciferase gene (Fig. 1B). C17 is a modified version of the previously 
described plasmid C17fluc-TaV2A, which has been proven to be a valuable tool for the 
investigation of specific sequence elements that govern RNA translation and replication (16). 
In addition to the mutants described and characterized in detail below, two replicons were 
used as control throughout this study: 5’-∆AUG, a construct lacking the entire capsid coding 
sequence starting from nucleotide position 133 including the 5’-SL3 (the stem-loop 
containing the viral translational START codon, Fig. 1C). This construct was used as a 
negative control for viral translation. As a translation competent control that is unable to 
replicate we used NS5-GAA, a construct corresponding to the wild-type replicon but carrying 
a mutated active site motif (GDD to GAA) of the viral RNA-dependent RNA polymerase 
(NS5),(16). 
 
Analysis of the 5’ stem-loop structure 2 (5’-SL2) 
The 5’-SL2 contains the 5’-part of the TBEV CS-A element (Fig. 1A, in green). This CS-
A element has been characterized previously (12). It has been shown by the introduction of 
point mutations that the long range interaction with the CS-A element in the viral 3’-NCR is 
crucial for RNA replication. Mutations in the 5’-CS-A element that impede the long-range 
interaction with the viral 3’-end, can be counterbalanced by compensatory mutations in the 
3’-part of CS-A (12).  
To investigate the importance of the 5’-SL2 formation, we engineered mutants carrying 
point mutations outside the CS-A motif that would interfere with or stabilize the stem-loop 
structure. The mutants 5’-SL2mut3 and 5’-SL2mut6 contain three, and six nucleotide 
changes, respectively (Fig. 2A, upper panel), that affect internal base pairing of the 5’-SL2. 
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The new sequences were predicted to fold into a significantly different structure (not shown). 
For both mutants, however, the potential to establish long-range interactions with the 3’-CS-A 
element is fully maintained according to thermodynamic analysis (Fig. 2A, bottom). A further 
mutant destabilizing the 5’-SL2 but still allowing the formation of the stem was generated, i.e. 
5’-SL2mut2 (Fig. 2A). In addition we sought to augment the stability of 5’-SL2 by extending 
its stem by three additional G-C base pairs at its bottom end (construct 5’-SL2stab, Fig. 2A). 
The calculated stability for the 5’-SL2 in 5’-SL2stab is strongly increased compared to C17 
(Fig. 2A, bottom). As a consequence, long range interaction with the 3’-CS-A element are 
rendered thermodynamically unfavorable due to the inability of this stem to open up.  
To determine the effects of 5’-SL2 stabilization and destabilization on RNA translation 
and replication, the parental C17 and the above described mutant replicon RNAs were 
transcribed in vitro and equimolar amounts of RNA were transfected into BHK-21 cells. 
Renilla-standard RNA for an early time point (3 hours) and Renilla-standard DNA for later 
time points (15.5 – 72 hours) respectively, were coelectroporated with the firefly constructs 
followed by the measurement of both luc activities. The normalized luc signal at 3 hours 
posttransfection was representative for the translation activity. To asses RNA replication, we 
analyzed luc activities from 15.5 to 72 hours. 
Transfection with mutants destabilizing and stabilizing the 5’-SL2 exhibited fluc 
activities similar to those transfected with C17 3 hours posttransfection (Fig. 2B), indicating 
that the stability of this stem-loop did not have an effect on viral RNA translation. However, 
significant differences were seen at later time points (Fig. 2C) indicating that the mutations 
influenced RNA replication. Destabilization of 5’-SL2 led to impairment of RNA replication in 
an order corresponding to the degree of destabilization (mut6>mut3>mut2). Remarkably, the 
mutants 5’-SL2mut3 and 5’-SL2mut6 in which 5’-SL2 is predicted to not form at all, exhibited 
more than twenty fold less luciferase activity than the parental replicon C17 at 15.5 to 72 
hours after electroporation (Fig. 2C). Furthermore, 5’-SL2stab was entirely negative for RNA 
replication, although translation was not impaired. This is in good agreement with 
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thermodynamic calculations which yielded a negative ∆∆G value indicative of an inability of 
this mutant to induce long range interactions of 5’-CS-A with the 3’-CS-A element.   
Taken together these results demonstrate that stability and formation of 5’-SL2 does 
not affect RNA translation, but a balanced stability equilibrium of this motif is necessary for 
efficient RNA replication. Both formation of 5’-SL2 and its ability to open up are required, 
providing indirect but compelling evidence that the viral RNA molecule assumes different 
conformations during its replication cycle.  
 
Analysis of the 5’ stem-loop structure 3 (5’-SL3) 
An obvious and important feature of the TBEV 5’-SL3 is the presence of the 
translational AUG start codon in the 5’-arm of this RNA secondary structure motif (Fig. 1A). 
The exact mechanisms for flaviviral input RNA translation are unknown. Different from 
mosquito-borne flaviviruses, the start codon of TBEV is in a strong Kozak initiation context 
suggesting that translation occurs by cap dependent initiation followed by ribosome scanning 
through the 5’-NCR. To analyze the role of 5’-SL3 we generated two mutants destabilizing 
the stem (5’-SL3mut2 and 5’-SL3mut5) and one construct with a stabilized and elongated 
hairpin (5’-SL3stab) as depicted in Fig. 3A. The destabilized hairpin of mutant 5’-SL3mut2 
was constructed to maintain the strong Kozak sequence, whereas the overall potential to 
build the hairpin structure was lowered according to the calculated stem-loop base pairing 
probability (Fig. 3A, bottom). The five destabilizing mutations in 5’-SL3mut5 were predicted to 
induce formation of a significantly different stem-loop structure (structure not shown). 
However, the strong Kozak initiation context was preserved and the mutations did not alter 
the encoded amino acid sequence.  
Surprisingly, the destabilized mutant 5’-SL3mut2 did not exhibit a difference in the 
translation of the viral input RNA compared to C17 but had a distinct defect in RNA 
replication (Fig. 3B, C). A more than twenty-fold reduction of fluc levels was observed for this 
mutant at the later time points. Complete breakup of the original hairpin element (5’-
SL3mut5) resulted in a similar impairment of RNA replication as destabilization did in 5’-
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SL3mut2. In addition, there also seemed to be a slight effect on RNA translation in 5’-
SL3mut5.  An even stronger negative effect on translation, however, was caused by the 
stabilization of the stem-loop element (5’-SL3stab). Compared to C17 the translational peak 
of the viral input RNA was reduced more than 40%. Noticeably, the stabilization did not 
interfere with RNA replication as much as destabilization did. 
These data suggest that the formation of the 5’-SL3 is necessary for optimal RNA 
replication. This is, although somehow surprising as the 5’-SL3 of TBEV does not contain the 
viral 5’-cyclization sequence, not directly comparable to the situation in mosquito-borne 
flaviviruses (DENV, WNV), where the translational start codon is contained within the 
secondary structure motif that also bears the 5’-UAR cyclization element. Moreover these 
results indicate that the formation of the stem-loop is only of little if any importance for RNA 
translation and that it can actually even impair the translational process if the stability of the 
structure is artificially augmented (5’-SL3stab). The latter observation likely reflects a 
consequence of the incurred restriction of the stabilized structure to get unwound during the 
viral RNA translation process. As seen with 5’-SL2, a balanced stability equilibrium seems 
therefore to be required for optimal functionality of the 5’-SL3.  
 
Analysis of the 5’ stem-loop structure 4 (5’-SL4) 
 In contrast to TBEV and other tick-borne-flaviviruses, mosquito-borne flaviviruses 
generally lack a strong Kozak initiation context. Recently it has been demonstrated that a 
short hairpin structure element downstream of the translational start codon, the cHP element, 
directs start codon selection and is responsible for high efficiency translation initiation from 
this AUG (15). Furthermore it has been found that the cHP element has a role in DENV RNA 
replication and that it operates in a sequence independent manner (14,15).  
 A stable, highly conserved hairpin structure element, the 5’-SL4 (Fig. 1A), is also 
present in the capsid coding region of tick-borne flaviviruses and it has been speculated 
earlier that this hairpin represents the TBEV analog of the mosquito-borne cHP and has been 
maintained by sequence covariation (15). Notably, however, the spacing between the TBEV 
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AUG startcodon and the 5’-SL4 is larger than the distance between the mosquito-borne AUG 
and the cHP. Given the fact that the TBEV virus AUG is in a strong Kozak initiation context 
and considering that the 5’-SL4 is not situated in a distance from the startcodon that would 
correspond to a ribosomal footprint (12-15 nt), it remained so far unclear whether the 5’-SL4 
has a similar function in TBEV RNA synthesis or RNA translation than the mosquito-borne 
cHP element. 
 To address this question, we first performed a thermodynamic analysis of the TBEV 5’-
SL4 structure. Interestingly, the results revealed an exceptionally high potential of the stem-
loop to form several slightly different variants, i.e. different from other structures such as 5’-
SL2 or 5’-SL3 there is not a single overall dominating secondary structure formation. At least 
three different hairpins are likely to occur at this position in a pool of viral RNAs (Fig. 4A, 5’-
SL4 wt).This “secondary-structure ensemble” is caused by a series of 6 consecutive Gs at 
the 5’-arm of the stem-loop, and a series of 5 consecutive Cs at its 3’-end, which allows the 
stem-loop to shift for one or two nucleotides in 5’- or 3’-direction without a significant change 
in thermodynamic stability. According to our computational analysis this feature is specific for 
the tick-borne 5’-SL4 element and does not apply to the mosquito-borne cHP element 
(unpublished observation). We then wanted to investigate the role of this conserved stem-
loop ensemble in viral RNA replication and translation, and also unravel a potential relevance 
of its extraordinary structural flexibility in any of these processes. To this end, we generated 
three different mutants (Fig. 4A). In 5’-SL4mut3, three nucleotide changes were engineered 
that – according to thermodynamic analysis – abolished the flexibility of the hairpin element 
by the introduction of a G-C anchor in the middle of the stem region. Thus, although the 
flexibility of this mutant was predicted to be destroyed by enforcing the formation of a single 
variant, the overall stability of the resulting hairpin was largely unchanged, compared to the 
wild-type structure ensemble. An opposite outcome was achieved with mutant 5’-SL4stab. 
Three additional G-C pairs were introduced at the base of the stem, resulting in an 
elongation and strong stabilization of the resulting hairpin structures, whereas the potential of 
these stabilized hairpins to slide was retained similar to the wild-type structure. In mutant 
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C10, the entire 5’-SL4 sequence element was deleted (The mutant designation C10 indicates 
that only the first 10
All three replicons were tested for translation and replication as described before. 
Deletion of 5’-SL4 significantly impaired RNA translation by approximately 50%. Interestingly, 
the reduction of its structural flexibility (as achieved in mutant 5’-SL4mut3) also reduced 
translation. Although this mutant maintains one structure of the original ensemble, the 
luciferase assay revealed a more than 30% diminished translation efficiency, compared to 
the wildtype control C17 (Fig. 4B). In contrast, the elongation and stabilization of 5’-SL4 did 
not affect translation of input RNA (5’-SL4stab, Fig. 4B). This indicated that the presence 
and, notably, also the structural flexibility of 5’-SL4 can augment TBEV virus RNA translation.  
 amino acids of the capsid protein are encoded, whereas C17 and all 
derivatives encode the first 17 residues). 
The subsequent analysis of viral RNA replication revealed a moderate reduction in fluc 
levels obtained with C10 and 5’-SL4mut3 (Fig. 4C) indicating that the 5’-SL4 might also be 
involved in TBEV RNA replication. This would support earlier work of Clyde et al., who 
suggested that the mosquito-borne cHP element and the corresponding element in tick-
borne flaviviruses originally arose as a replication element that was only later recruited for 
translation initiation site selection in viruses that lack a strong Kozak initiation context, such 
as DENV or WNV (14). Most interestingly, however, the stabilization of the TBEV 5’-SL4 
seemed to increase viral replication levels compared to the wild-type control at any time point 
included in our measurements. In contrast to the results obtained with 5’-SL2 and 5’-SL3, 
where a stability equilibrium of the secondary structure elements was either important for 
translation or replication, stabilization of 5’-SL4 did not appear to have a detrimental effect on 
any of these processes. This finding is in good agreement with a recent observation in DENV 
infected cells: Although it was found that destabilization of the cHP-element drastically 
decreased the titer of infectious virus, a more stable cHP element did not impact viral output 
or affect the kinetics of viral infection in human and mosquito cells (14).  
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Collectively, our results suggest that the TBEV 5’-SL4 contributes to translation 
initiation and also assists in viral RNA replication, a role that might be closely related to the 
proposed function of the mosquito-borne cHP element.  
Material and Methods 
 
Plasmids and cells 
Replicon constructs in this study are all derivates of the cDNA clone of TBEV Western 
subtype prototypic strain Neudoerfl (GenBank Accession no. U27495). As parental construct 
the C17 replicon (described in Rouha et al., submitted) was used. Briefly, C17 lacks most of 
the structural protein coding region, replaced by the insertion of a firefly luciferase (fluc) 
followed by a 60-nucleotide-long 2A processing site of Thosea asigna virus. The firefly 
luciferase start codon (AUG) was deleted. Replicon cDNAs of all constructs were driven by a 
T7 promoter for in vitro transcription.  
 
Cell culture 
BHK-21 cells (ATCC CL10) were grown in Eagle’s minimal essential medium (EMEM) 
supplemented with 5% fetal calf serum (FCS). The cells were electroporated using a 
GenePulser apparatus (Bio-Rad) as described previously (17). After transfection, the growth 
medium was replaced by a maintenance medium consisting of EMEM without phenol red 
(Cambrex), containing 1% FCS. 
 
Mutant construction (5’-terminal region) 
The C17 replicon was generated by the deletion of the start codon at position 132-134 
(numbering according to the full-length sequence of strain Neudoerfl) using the forward 
mutagenesis primer F-fluc-AUGdel (GCCTTAATTAAGGAAGACGCCAAAAACAT), reverse 
primer R-E1 (TCTCCACACGACCAGGCCCT) and C17fluc-TaV2A as template for PCR 
amplification (Rouha et al., submitted). Replicon ∆AUG, that contained a deletion of 130-183 
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nucleotides (nt) and C10fluc with a deletion of 163 to 183 nt, were constructed by PCR 
amplification with the forward primer F-SalIreg (GCATCGGTCGACTTAATACGA) and the 
reverse primer NS1_SS_R (GCTCATGGACATTGTAGGGTTTCT), using the previously 
described plasmid clones ∆5’ -SL3 and C10. The PCR products were trimmed with SalI and 
PacI replacing a fragment extending from a SalI site preceding the T7 promoter to a PacI site 
at nucleotide 184 with the corresponding region from C17. The replicon 5’-SL4mut3 was 
created by amplification using as template a partial cDNA clone C17∆CME (containing the 
region extending from a unique SalI restriction site to the unique ClaI site at position 3155 
within the NS1 coding region) and primer SalIreg and mutagenic primer R-5’-SL4mut3 
GGTCTTAATTAATCGTCGAGGCGGCCCGCCGC (the SalI recognition site is in cursive and 
the mutations in bold letters). 
Plasmid 5’-SL2stab was constructed by three-step PCR using the mutagenic primer  R-
3’-SL2stab 5’-GGGCAGCTCTTGTTCTCCTAAGCTGCCCTCTTTTTCTCAACACGTT-3’ and 
F-5’-SL2stab 5’-GGGCAGCTTAGGAGAACAAGAGCTGCCCGGGATGGTCAAGAAGGC-3’. 
The mutants 5’-SL2mut2 and 5’-SL2mut3 were generated, using a GeneTailor Site-Directed 
Mutagenesis System (Invitrogen), with mutagenic forward primers F-5’-SLmut2 (5’-
CGTGTTGAGAAAAAGACAGCCGAGGAGAACAA-3’), F-5’-SLmut3 (5’- 
ACGTGTTGAGAAAAAGACCCGTTAGGAGAA) and a wild type reverse primer.  
To generate all other mutants, bearing various mutations at their 5’-termini, the region 
from SalI and PacI was synthesized by GeneArt (Germany) then inserted into the C17 
replicon, taking advantage of the corresponding SalI and PacI restriction sites. 
As replication negative control NS5-GAA was used containing a mutation within the 
RNA dependent RNA polymerase (RdRp) active site at position 9652-9660 (GDD to GAA) 
(Hoenninger et al., 2008). All plasmids were amplified in Escherichia coli HB101 and purified 
with commercially available systems (Qiagen).  
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RNA in vitro transcription, transfection and luciferase assay 
RNA was transcribed from 1 µg aliquots of the plasmid DNA by T7 polymerase 
transcription, using commercially available reagents (Ambion) and conditions described in 
detail elsewhere  (17). Briefly, after the transcription reaction, template DNA was digested by 
DNAseI incubation, purified and separated by unincorporated nucleotides by using an 
RNeasy Mini-Kit (Qiagen).  RNA was then spectrophotometrically quantified and equal 
amounts (corresponding to approximately 1.4 x 1012 copies) were introduced into BHK-21 
cells by electroporation with a Bio-Rad Gene Pulser, as described previously (17). For 
standardization the hRLSV40 plasmid (Promega) and an RNA expressing the Renilla 
luciferase was made by first linearizing the plasmid phRL-SV40 (Promega) with BamHI, 
followed by in vitro transcription, using the same procedure as described for the mutant 
constructs, respectively. The luciferase assay and standardization was performed as 
described elsewhere (Hoenninger et al. 2008). 
 
Folding predictions 
For all calculations of secondary structures we used the “Vienna RNApackage” (18). 
Calculations of the complete sequence of the wt genome C17 as well as all mutant contructs 
in this study revealed long range interactions, that lead to a panhandle like overall genome 
structure. For calculation of 5'- and 3'-secondary structures as shown in Fig.1 we 
recalculatetd the complete sequence with the constraints, that nt 115-123 and nt 11060-
11063, 11068-11071 were not allowed to participate in any secondary structure. We obtained 
the secondary structures as shown in Fig. 1A for 5'- and 3'-terminal regions of the genome 
respectively. As closer inspection of folding probabilities showed that there was no 
secondary structures starting at the first 194 nucleotides that folded towards sections of the 
genome more downstream, we decided that it was feasible to use the first 194 nts to be a 
long enough template for estimating the ∆G and ∆∆G values of the stem-loops 5’- SL2, 5’-
SL3 and 5’-SL4. As a reference value for the Gibbs free energy of the stem-loops 5’-SL2, 5’-
SL3 and 5’-SL4, we calculated the difference between the Gibbs free energies of the first 194 
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nts with and without the constraint that the respective stem loops were allowed to form. We 
repeated the same calculations using the mutant sequences and thus obtained the 
contribution of the mutated stem loops to the overall Gibbs free energy of the structure. The 
difference of the Gibbs free energy of the mutated stem loops and the respective wt version 
of the stem loop revealed an energy value ∆∆G, indicating the degree of stabilization 
(positive values) or destabilization (negative values).  
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Figure Legends 
 
Figure 1 
Genome secondary structure and organization of TBEV and derived replicon 
constructs. (A) TBEV. The stem-loop structures are shown as predicted for the linear form, 
without consideration of the long-range interaction of the cyclization sequence (depicted in 
green) in the viral 5’-SL2 and 3’-SL2. The viral start codon AUG in the 5’-SL3 is highlighted in 
grey. (B) Generalized scheme of the parental replicon C17 that has the structural protein 
region of TBEV replaced by an in-frame insertion of the firefly luciferase gene (fluc). C17, 
truncated Capsid coding gene; E472, codon 472 of the E protein gene; NS1-NS5, the coding 
region for the non-structural proteins 1-5; NCR, noncoding region. (C) Schematic diagram of 
mutant replicon ∆AUG that lacks the entire capsid coding sequence starting from nucleotide 
position 133 including the 5’-SL3, containing the viral start codon. Diagrams A-C are not 
drawn to scale. 
 
Figure 2 
Characterization of 5’-SL2. (A) Top. Schematic drawing of the predicted secondary 
structure for wild-type 5’-SL2 (bold letters) and engineered mutant replicons. Nucleotide 
changes are depicted in red. Bottom. Thermodynamic analysis of wild-type 5’-SL2 and the 
respective mutants. ∆G, Gibbs free energy of the secondary structure of a segment of the 
first 194 nucleotides of the viral genome; ∆Gconst, Gibbs free energy of the same segment 
calculated with the constraint that SL2 is not allowed to form; ∆Grel, difference of ∆G and 
∆Gconst and thus the energetic contribution of SL2 (wt, mut2, mut3, mut6 and stab 
respectively) to the overall energy of the calculated segment; ∆∆G, the difference of ∆Grel of 
the respective stem to the ∆Grel of the wt; positive values correspond to destabilization 
whereas negative values reflect stabilization of the stem-loop. (B) Translation level of viral 
input RNA 3 hours posttransfection into BHK-21 cells. Normalized luciferase levels are 
shown as percentage relative to the parental control C17. RNA of construct ∆AUG, lacking 
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the viral translational start codon AUG, was used as a negative control. Error bars represent 
standard deviation of at least two independent experiments (C) Viral RNA replication 
efficiencies of the parental C17 replicon and mutants derived from it, monitored by 
normalized firefly luciferase activity in BHK-21 cells 15.5 - 72 hours posttransfection. Capped 
NS5-GAA RNA, which can be translated but cannot replicate due to a GDD to GAA mutation 
in the viral RNA polymerase gene NS5, was used as a control. Error bars represent the 
standard deviation of two independent experiments, each measured in triplicate.  
 
Figure 3 
Characterization of 5’-SL3. (A) Top. Schematic drawing of the predicted secondary 
structure for wild-type 5’-SL3 (bold letters) and engineered mutant replicons. Nucleotide 
changes are depicted in red. Thermodynamic analysis of wild-type 5’-SL3 and the respective 
mutants. ∆G, Gibbs free energy of the secondary structure of a segment of the first 194 
nucleotides of the viral genome; ∆Gconst, Gibbs free energy of the same segment calculated 
with the constraint that SL3 is not allowed to form; ∆Grel, difference of ∆G and ∆Gconst and thus 
the energetic contribution of SL3 (wt, mut2, mut5 and stab respectively) to the overall energy 
of the calculated segment; ∆∆G, the difference of ∆Grel of the respective stem to the ∆Grel of 
the wt; positive values correspond to destabilization whereas negative values reflect 
stabilization of the stem-loop. (B) Translation level of viral input RNA 3 hours posttransfection 
into BHK-21 cells. Normalized luciferase levels are shown in % relative to the parental 
control C17. RNA of construct ∆AUG, lacking the viral translational start codon AUG, was 
used as a negative control. Error bars represent standard deviation of at least two 
independent experiments (C) Viral RNA replication efficiencies of the parental C17 replicon 
and mutants derived from it, monitored by normalized firefly luciferase activity in BHK-21 
cells 15.5 - 72 hours posttransfection. Capped NS5-GAA RNA, which can be translated but 
cannot replicate due to a GDD to GAA mutation in the viral RNA polymerase gene NS5, was 
used as a control. Error bars represent the standard deviation of two independent 
experiments, each measured in triplicate.  
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Figure 4 
Characterization of 5’-SL4. (A) Top. Schematic drawing of the predicted secondary 
structures for wild-type 5’-SL4 (bold letters) and engineered mutant replicons. Nucleotide 
changes are depicted in red. Structures shown in the middle are the ones that have the 
highest probability to be formed in the structure ensemble. Arrows indicate a shift in another 
secondary structure of the same stem-loop element (see text for details). Hairpins which are 
not predicted to be formed any more as a result of the introduced mutations or hairpins that 
have been deleted (red cross) are shown in light grey. Bottom. Thermodynamic analysis of 
wild-type (C17) and the respective mutants. ∆G, Gibbs free energy of the secondary 
structure of a segment of the first 194 nucleotides of the viral genome; ∆Gconst, Gibbs free 
energy of the same segment calculated with the constraint that SL4 is not allowed to form; 
∆Grel, difference of ∆G and ∆Gconst and thus the energetic contribution of SL4 (wt, mut3 and 
stab respectively) to the overall energy of the calculated segment; ∆∆G, the difference of 
∆Grel of the respective stem to the ∆Grel of the wt; positive values correspond to 
destabilization whereas negative values reflect stabilization of the stem-loop. (B) Translation 
level of viral input RNA 3 hours posttransfection into BHK-21 cells. Normalized luciferase 
levels are shown in % relative to the parental control C17. RNA of construct ∆AUG, lacking 
the viral translational start codon AUG, was used as a negative control. Error bars represent 
standard deviation of at least two independent experiments (C) Viral RNA replication 
efficiencies of the parental C17 replicon and mutants derived from it, monitored by 
normalized firefly luciferase activity in BHK-21 cells 15.5-72 hours posttransfection. Capped 
NS5-GAA RNA, which can be translated but cannot replicate due to a GDD to GAA mutation 
in the viral RNA polymerase gene NS5, was used as a control. Error bars represent the 
standard deviation of two independent experiments, each measured in triplicate. 
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